Somatically mutated cancer genes.

This table is a list of the cancer genes that are somatically mutated.The full version of this table can be downloaded here .This is part of Table 1 in Futreal et al.

Symbol	Name	Entrez GeneID	Chr	Chr Band	Tumour Types (Somatic Mutations)	Synonyms
ABL1	v-abl Abelson murine leukemia viral oncogene homolog 1	25	9	9q34.1	CML, ALL, T-ALL	25, ABL, ABL1, ENSG00000097007, JTK7, P00519, bcr/abl, c-ABL, p150, v-abl
ABL2	v-abl Abelson murine leukemia viral oncogene homolog 2	27	1	1q24-q25	AML	27, ABL2, ABLL, ARG, ENSG00000143322, P42684, RP11-177A2_3
ACSL3	acyl-CoA synthetase long-chain family member 3	2181	2	2q36	prostate	2181, ACS3, ACSL3, ASPM, CCDS2455.1, ENSG00000123983, FACL3, O95573, PRO2194, Q6PIM8
AF15Q14	AF15q14 protein	57082	15	15q14	AML	57082, AF15Q14, CASC5, D40, ENSG00000137812, Q8NG31
AF1Q	ALL1-fused gene from chromosome 1q	10962	1	1q21	ALL	10962, AF1Q, CCDS982.1, ENSG00000213190, MLLT11, Q13015, Q6FGF7
AF3p21	SH3 protein interacting with Nck, 90 kDa (ALL1 fused gene from 3p21)	51517	3	3p21	ALL	51517, AF3P21, AF3p21, CCDS2776.1, ENSG00000213672, NCKIPSD, ORF1, Q6GU34, Q8TC10, Q9NZQ3, SPIN90, WASLBP, WISH
AF5q31	ALL1 fused gene from 5q31	27125	5	5q31	ALL	27125, AF5Q31, AF5q31, AFF4, CCDS4164.1, ENSG00000072364, MCEF, Q9UHB7
AKAP9	A kinase (PRKA) anchor protein (yotiao) 9	10142	7	7q21-q22	papillary thyroid	10142, AKAP350, AKAP450, AKAP9, AKAP9_ENST00000356239, AKAP9_NM_005751, B3KQF9, CCDS5622, CG-NAP, ENSG00000127914, HYPERION, KIAA0803, MU-RMS-40_16A, PRKA9, Q5GIA7, Q8IW64, Q99996, YOTIAO
AKT1	v-akt murine thymoma viral oncogene homolog 1	207	14	14q32.32	breast, colorectal, ovarian, NSCLC	207, AKT, AKT1, AKT1_NEW, B0LPE5, B2RAM5, B3KVH4, B3KXD7, B7Z5R1, CCDS9994, ENSG00000142208, MGC99656, P31749, PKB, PKB-ALPHA, PRKBA, Q9BV07, RAC, RAC-ALPHA
AKT2	v-akt murine thymoma viral oncogene homolog 2	208	19	19q13.1-q13.2	ovarian, pancreatic	208, AKT2, CCDS12552.1, ENSG00000105221, P31751, PKBBETA, PRKBB, RAC-BETA
ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	217	12	12q24.2	leiomyoma	217, ALDH-E2, ALDH2, ALDHI, ALDM, CCDS9155.1, ENSG00000111275, MGC1806, P05091, Q53FB6, Q9UN17
ALK	anaplastic lymphoma kinase (Ki-1)	238	2	2p23	ALCL, NSCLC, Neuroblastoma	238, ALK, CD246, ENSG00000171094, Q9UM73, TFG/ALK
ALO17	KIAA1618 protein	57714	17	17q25.3	ALCL	57674, ALO17, C17orf27, CCDS32761.1, ENSG00000173821, KIAA1554, Q63HN8, Q6ZSK6, RNF213
APC	adenomatous polyposis of the colon gene	324	5	5q21	colorectal, pancreatic, desmoid, hepatoblastoma, glioma, other CNS	324, APC, CCDS4107.1, DP2, DP2_5, DP3, ENSG00000134982, FAP, FPC, GS, P25054
ARHGEF12	RHO guanine nucleotide exchange factor (GEF) 12 (LARG)	23365	11	11q23.3	AML	23365, ARHGEF12, DKFZp686O2372, ENSG00000196914, KIAA0382, LARG, PRO2792, Q6P526, Q9NZN5
ARHH	RAS homolog gene family, member H (TTF)	399	4	4p13	NHL	399, ARHH, CCDS3458.1, ENSG00000168421, RHOH, RhoH, TTF
ARID1A	AT rich interactive domain 1A (SWI-like)	8289	1	1p35.3	clear cell ovarian carcinoma, RCC	8289, ARID1A, B120, BAF250, BAF250a, BM029, C1orf4, ENSG00000117713, P270, RP1-50O24_1, SMARCF1
ARID2	AT rich interactive domain 2	196528	12	12q12	hepatocellular carcinoma	196528, ARID2, BAF200, CCDS31783.1, DKFZp686G052, DKFZp779P0222, ENSG00000189079, FLJ30619, KIAA1557, Q15KG9, Q4G0S8, Q68CP9, Q8NBP1, Q8WV72, Q96DQ8, Q96SQ4, p200
ARNT	aryl hydrocarbon receptor nuclear translocator	405	1	1q21	AML	405, ARNT, CCDS970.1, ENSG00000143437, HIF-1beta, HIF1B, HIF1BETA, O43392, P27540, Q53F30, Q59ED4, Q5QP39, Q6P9C1, TANGO
ASPSCR1	alveolar soft part sarcoma chromosome region, candidate 1	79058	17	17q25	alveolar soft part sarcoma	79058, ASPSCR1, CCDS11796.1, ENSG00000169696, Q9BZE9
ASXL1	additional sex combs like 1	171023	20	20q11.1	MDS, CMML	171023, ASXL1, CCDS13201.1, ENSG00000171456, KIAA0978, MGC117280, MGC71111, Q498B9, Q6P1M8, Q8IXJ9
ATF1	activating transcription factor 1	466	12	12q13	malignant melanoma of soft parts , angiomatoid fibrous histiocytoma	466, ATF1, CCDS8803.1, ENSG00000123268, P18846, TREB36
ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	471	2	2q35	ALCL	471, AICARFT, ATIC, CCDS2398.1, ENSG00000138363, IMPCHASE, P31939, PURH, Q53S28
ATM	ataxia telangiectasia mutated	472	11	11q22.3	T-PLL	472, AT1, ATA, ATC, ATD, ATDC, ATE, ATM, DKFZp781A0353, ENSG00000149311, MGC74674, Q13315, TEL1, TELO1
ATRX	alpha thalassemia/mental retardation syndrome X-linked	546	X	Xq21.1	Pancreatic neuroendocrine tumors, paediatric GBM	546, A4LAA3, A8MTN6, ATR2, ATRX, ATRX_ENST00000373344, B4DHH8, B4DLE1, B4DLW1, B7Z1D8, CCDS14434, D3DTE2, MGC2094, MRXHF1, P46100, Q86U63, RAD54, RAD54L, SFM1, SHS, XH2, XNP, ZNF-HX
BAP1	BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)	8314	3	3p21.31-p21.2	uveal melanoma, breast, NSCLC, RCC	8314, BAP1, CCDS2853.1, DKFZp686N04275, ENSG00000163930, FLJ35406, FLJ37180, HUCEP-13, KIAA0272, Q92560, hucep-6
BCL10	B-cell CLL/lymphoma 10	8915	1	1p22	MALT	8915, BCL10, CARMEN, CCDS704.1, CIPER, CLAP, ENSG00000142867, c-E10, mE10
BCL11A	B-cell CLL/lymphoma 11A	53335	2	2p13	B-CLL	53335, BCL11A, BCL11A-L, BCL11A-S, BCL11A-XL, CCDS1862.1, CTIP1, ENSG00000119866, EVI9, FLJ10173, FLJ34997, KIAA1809, Q53TE8, Q53TS1, Q9H165
BCL11B	B-cell CLL/lymphoma 11B (CTIP2)	64919	14	14q32.1	T-ALL	64919, BCL11B, CCDS9950.1, CTIP-2, CTIP2, ENSG00000127152, Q9C0K0, RIT1, hRIT1-alpha
BCL2	B-cell CLL/lymphoma 2	596	18	18q21.3	NHL, CLL	596, BCL2, Bcl-2, CCDS11981.1, ENSG00000171791
BCL3	B-cell CLL/lymphoma 3	602	19	19q13	CLL	602, BCL3, BCL4, CCDS12642.1, D19S37, ENSG00000069399, P20749
BCL5	B-cell CLL/lymphoma 5	603	17	17q22	CLL
BCL6	B-cell CLL/lymphoma 6	604	3	3q27	NHL, CLL	604, BCL5, BCL6, BCL6A, CCDS3289.1, ENSG00000113916, LAZ3, P41182, ZBTB27, ZNF51
BCL7A	B-cell CLL/lymphoma 7A	605	12	12q24.1	BNHL	605, BCL7, BCL7A, ENSG00000110987
BCL9	B-cell CLL/lymphoma 9	607	1	1q21	B-ALL	607, BCL9, ENSG00000116128, LGS, MGC131591
BCOR	BCL6 corepressor	54880	X	Xp11.4	retinoblastoma, AML, APL(translocation)	54880, ANOP2, BCOR, CCDS14250.1, ENSG00000183337, FLJ20285, FLJ38041, KIAA1575, MAA2, MCOPS2, MGC131961, MGC71031
BCR	breakpoint cluster region	613	22	22q11.21	CML, ALL, AML	613, ALL, BCR, BCR1, CCDS13806.1, CML, D22S11, D22S662, ENSG00000186716, FLJ16453, P11274, PHL
BIRC3	baculoviral IAP repeat-containing 3	330	11	11q22-q23	MALT	330, AIP1, API2, BIRC3, CCDS8315.1, CIAP2, ENSG00000023445, HAIP1, HIAP1, MALT2, MIHC, Q13489, RNF49, cIAP2, hiap-1
BRAF	v-raf murine sarcoma viral oncogene homolog B1	673	7	7q34	melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma	673, B-raf 1, B-raf1, BRAF, BRAF1, CCDS5863.1, ENSG00000157764, MGC126806, MGC138284, P15056, RAFB1
BRCA1	familial breast/ovarian cancer gene 1	672	17	17q21	ovarian	672, BRCA1, BRCAI, BRCC1, ENSG00000012048, IRIS, PSCP, RNF53
BRCA2	familial breast/ovarian cancer gene 2	675	13	13q12	breast, ovarian, pancreatic	675, BRCA2, BRCC2, ENSG00000139618, FACD, FAD, FAD1, FANCB, FANCD, FANCD1, RP11-298P3_4
BRD3	bromodomain containing 3	8019	9	9q34	lethal midline carcinoma of young people	8019, BRD3, ENSG00000169925, KIAA0043, ORFX, Q15059, RING3L
BRD4	bromodomain containing 4	23476	19	19p13.1	lethal midline carcinoma of young people	23476, BRD4, BRD4_ENST00000263377, CAP, CCDS12328, ENSG00000141867, HUNK1, HUNKI, MCAP, O60885, Q05BM2, Q5BJ26, Q6NXE4, Q6PIS5, Q96HN0
BTG1	B-cell translocation gene 1, anti-proliferative	694	12	12q22	BCLL	694, BTG1, CCDS9043.1, ENSG00000133639, P62324, Q6IBC8
C12orf9	chromosome 12 open reading frame 9	93669	12	12q14.3	lipoma
C15orf21	chromosome 15 open reading frame 21	283651	15	15q21.1	prostate
C15orf55	chromosome 15 open reading frame 55	256646	15	15q14	lethal midline carcinoma	256646, C15orf55, CCDS32190.1, ENSG00000184507, NUT, Q86Y26, Q86YS8, Q9NTB3
C16orf75	chromosome 16 open reading frame 75	116028	16	16p13.13	PMBL, Hodgkin Lymphona,	116028, C16orf75, CCDS10548.1, ENSG00000175643, MGC24665, Q96E14, RMI2
C2orf44	chromosome 2 open reading frame 44	80304	2	2p23.3	NSCLC	80304, C2orf44, CCDS1705.1, ENSG00000163026, FLJ21945, PP384, Q8IYK0, Q9H6R7, Q9HBP5
CAMTA1	calmodulin binding transcription activator 1	611501	1	1p36.31-p36.23	epitheliod hemangioendothelioma	23261, CAMTA1, CCDS30576.1, ENSG00000171735, KIAA0833, Q7Z7P1, Q96S92, Q9Y6Y1
CANT1	calcium activated nucleotidase 1	124583	17	17q25	prostate	124583, CANT1, CCDS11760.1, ENSG00000171302, Q8WVQ1, SCAN-1, SHAPY
CARD11	caspase recruitment domain family, member 11	84433	7	7p22	DLBCL	84433, BIMP3, CARD11, CARMA1, CCDS5336.1, ENSG00000198286, MGC133069, Q9BXL7
CARS	cysteinyl-tRNA synthetase	833	11	11p15.5	ALCL	833, CARS, CCDS7742.1, ENSG00000110619, P49589, Q53HG6
CBFA2T1	core-binding factor, runt domain, alpha subunit 2;translocated to, 1 (ETO)	862	8	8q22	AML	862, CBFA2T1, CCDS6257.1, ENSG00000079102, Q7Z4J5, Q9HBV9, RUNX1T1
CBFA2T3	core-binding factor, runt domain, alpha subunit 2; translocated to, 3 (MTG-16)	863	16	16q24	AML	863, CBFA2T3, CCDS10972.1, ENSG00000129993, ETO2, MTG16, MTGR2, O60615, O60616, O60617, O75081, Q0P5Z6, ZMYND4
CBFB	core-binding factor, beta subunit	865	16	16q22	AML	865, CBFB, CCDS10827.1, ENSG00000067955, PEBP2B, Q13951, Q9HCT2
CBL	Cas-Br-M (murine) ecotropic retroviral transforming	867	11	11q23.3	AML, JMML, MDS	867, C-CBL, CBL, CBL2, CCDS8418.1, ENSG00000110395, RNF55
CBLB	Cas-Br-M (murine) ecotropic retroviral transforming sequence b	868	3	3q13.11	AML	868, CBLB, CCDS2948.1, DKFZp686J10223, DKFZp779A0729, DKFZp779F1443, ENSG00000114423, FLJ36865, FLJ41152, Nbla00127, RNF56
CBLC	Cas-Br-M (murine) ecotropic retroviral transforming sequence c	23624	19	19q13.2	AML	23624, CBL-3, CBL-SL, CBLC, CCDS12643.1, ENSG00000142273, Q9ULV8, RNF57
CCDC6	coiled-coil domain containing 6	8030	10	10q21	NSCLC	8030, CCDC6, CCDS7257.1, D10S170, ENSG00000108091, H4, PTC, Q05CP8, Q16204, Q6GSG7, TPC, TST1
CCNB1IP1	cyclin B1 interacting protein 1, E3 ubiquitin protein ligase	57820	14	14q11.2	leiomyoma	57820, C14orf18, CCDS9547.1, CCNB1IP1, ENSG00000100814, HEI10, Q9NPC3
CCND1	cyclin D1	595	11	11q13	CLL, B-ALL, breast	595, BCL1, CCDS8191.1, CCND1, D11S287E, ENSG00000110092, PRAD1, U21B31
CCND2	cyclin D2	894	12	12p13	NHL,CLL	894, CCDS8524.1, CCND2, ENSG00000118971, KIAK0002, MGC102758, P30279, Q53ER2
CCND3	cyclin D3	896	6	6p21	MM	896, CCDS4863.1, CCND3, ENSG00000112576, P30281, Q6FG62
CCNE1	cyclin E1	898	19	19q12	serous ovarian	898, CCDS12419.1, CCNE, CCNE1, ENSG00000105173, P24864
CD273	programmed cell death 1 ligand 2	80380	9	9p24.2	PMBL, Hodgkin Lymphona,	80380, B7DC, Btdc, CCDS6465.1, CD273, ENSG00000197646, MGC142238, MGC142240, PD-L2, PDCD1L2, PDCD1LG2, PDL2, Q2LC89, Q9BQ51, bA574F11_2
CD274	CD274 molecule	29126	9	9p24	PMBL, Hodgkin Lymphona,	29126, B7-H, B7H1, CCDS6464.1, CD274, ENSG00000120217, MGC142294, MGC142296, PD-L1, PDCD1L1, PDCD1LG1, PDL1, Q0GN75, Q9NZQ7
CD74	CD74 molecule, major histocompatibility complex, class II invariant chain	972	5	5q32	NSCLC	972, CCDS34276.1, CD74, DHLAG, ENSG00000019582, HLADG, Ia-GAMMA, O19685, Q8SNA0, Q9TNQ4, Q9TNQ6, protein 41
CD79A	CD79a molecule, immunoglobulin-associated alpha	973	19	19q13.2	DLBCL	973, CCDS12589.1, CD79A, ENSG00000105369, IGA, MB-1, P11912, Q53FB8
CD79B	CD79b molecule, immunoglobulin-associated beta	974	17	17q23	DLBCL	974, B29, CCDS11655.1, CD79B, ENSG00000007312, IGB, P40259
CDH1	cadherin 1, type 1, E-cadherin (epithelial) (ECAD)	999	16	16q22.1	lobular breast, gastric	999, Arc-1, CCDS10869.1, CD324, CDH1, CDHE, ECAD, ENSG00000039068, LCAM, P12830, UVO, uvomorulin
CDH11	cadherin 11, type 2, OB-cadherin (osteoblast)	1009	16	16q22.1	aneurysmal bone cysts	1009, CAD11, CCDS10803.1, CDH11, ENSG00000140937, OB, P55287, Q59EQ1, Q96CZ9
CDK12	cyclin-dependent kinase 12	51755	17	17q12	serous ovarian	51755, CCDS11337.1, CDK12, CRK7, CRKR, CRKRS, ENSG00000167258, KIAA0904, Q9NYV4
CDK6	cyclin-dependent kinase 6	1021	7	7q21-q22	ALL	1021, CCDS5628.1, CDK6, ENSG00000105810, MGC59692, PLSTIRE, Q00534
CDKN2A	cyclin-dependent kinase inhibitor 2A (p16(INK4a)) gene	1029	9	9p21	melanoma, multiple other tumour types	1029, ARF, CDK4I, CDKN2, CDKN2A, CMM2, ENSG00000147889, INK4, INK4a, MLM, MTS1, P42771, TP16, p14, p14ARF, p16, p16INK4, p16INK4a, p19
CDKN2C	cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)	1031	1	1p32	glioma, MM	1031, CCDS555.1, CDKN2C, ENSG00000123080, INK4C, P42773, Q6ICV4, Q9P1T2, p18, p18-INK4C
CDKN2a(p14)	cyclin-dependent kinase inhibitor 2A-- p14ARF protein	1029	9	9p21	melanoma, multiple other tumour types	1029, ARF, CCDS6511, CDK4I, CDKN2, CDKN2a(p14), CMM2, ENSG00000147889, INK4, INK4a, MLM, MTS1, Q5ZEY9, Q8N726, TP16, p14, p14ARF, p16, p16INK4, p16INK4a, p19
CDX2	caudal type homeo box transcription factor 2	1045	13	13q12.3	AML	1045, CCDS9328.1, CDX2, CDX3, ENSG00000165556, Q5VTU7, Q99626, Q9UD92
CEBPA	CCAAT/enhancer binding protein (C/EBP), alpha	1050	19	19q13.1	AML, MDS	1050, C/EBP-alpha, CEBP, CEBPA, P49715
CEP1	centrosomal protein 1	11064	9	9q33	MPD, NHL	11064, A2A2Y1, CCDS35118.1, CEP1, CEP110, CNTRL, ENSG00000119397, Q3MN79, Q5FWF8, Q5JVD0, Q5JVD1, Q5JVD6, Q6PKC1, Q7Z7A1, Q8TEP3, Q9Y489
CHCHD7	coiled-coil-helix-coiled-coil-helix domain containing 7	79145	8	8q11.2	salivary adenoma	79145, CCDS34896.1, CHCHD7, ENSG00000170791, FLJ40966, MGC2217, Q9BUK0
CHIC2	cysteine-rich hydrophobic domain 2	26511	4	4q11-q12	AML	26511, BTL, CCDS3493.1, CHIC2, Q9UKJ5
CHN1	chimerin (chimaerin) 1	1123	2	2q31-q32.1	extraskeletal myxoid chondrosarcoma	1123, ARHGAP2, CHN, CHN1, ENSG00000128656, RHOGAP2, RhoGAP2, n-chimerin
CIC	capicua homolog	23152	19	19q13.2	oligodendroglioma	23152, CCDS12601.1, CIC, ENSG00000079432, KIAA0306, Q96RK0
CIITA	class II, major histocompatibility complex, transactivator	4261	16	16p13	PMBL, Hodgkin Lymphona,	4261, A0N0N9, C2TA, CCDS10544.1, CIITA, ENSG00000179583, MHC2TA, P33076, Q29704, Q66X48, Q8SNB7, Q96KL4
CLTC	clathrin, heavy polypeptide (Hc)	1213	17	17q11-qter	ALCL, renal	1213, CCDS32696.1, CLTC, CLTCL2, ENSG00000141367, Q00610, Q49AL0
CLTCL1	clathrin, heavy polypeptide-like 1	8218	22	22q11.21	ALCL	8218, CLTCL, CLTCL1, ENSG00000070371, P53675
CMKOR1	chemokine orphan receptor 1	57007	2	2q37.3	lipoma	57007, CCDS2516.1, CMKOR1, CXCR7, ENSG00000144476, GPR159, P25106, RDC1
COL1A1	collagen, type I, alpha 1	1277	17	17q21.31-q22	dermatofibrosarcoma protuberans, aneurysmal bone cyst	1277, CCDS11561.1, COL1A1, ENSG00000108821, OI4, P02452, Q6LAN8, Q9UMA6
COPEB	core promoter element binding protein (KLF6)	1316	10	10p15	prostate, glioma	1316, BCD1, CCDS7060.1, COPEB, CPBP, DKFZp686N0199, ENSG00000067082, GBF, KLF6, PAC1, RP11-184A2_1, ST12, ZF9, Zf9
COX6C	cytochrome c oxidase subunit VIc	1345	8	8q22-q23	uterine leiomyoma	1345, CCDS6284.1, COX6C, ENSG00000164919, P09669
CREB1	cAMP responsive element binding protein 1	1385	2	2q34	clear cell sarcoma, angiomatoid fibrous histiocytoma	1385, CREB1, ENSG00000118260
CREB3L1	cAMP responsive element binding protein 3-like 1	90993	11	11p11.2	myxofibrosarcoma	90993, B2RA75, CREB3L1, ENSG00000157613, OASIS, Q96BA8
CREB3L2	cAMP responsive element binding protein 3-like 2	64764	7	7q34	fibromyxoid sarcoma	64764, A2RRN1, BBF2H7, CCDS34760.1, CREB3L2, ENSG00000182158, MGC131709, MGC71006, Q6ZMR6, Q70SY1, Q8IY69, TCAG_1951439
CREBBP	CREB binding protein (CBP)	1387	16	16p13.3	ALL, AML, DLBCL, B-NHL	1387, CBP, CCDS10509.1, CREBBP, ENSG00000005339, RSTS, RTS
CRLF2	cytokine receptor-like factor 2	64109	X,Y	Xp22.3; Yp11.3	B-ALL, Downs associated ALL	CRLF2, ENSG00000205755, Q4V300
CRTC3	CREB regulated transcription coactivator 3	64784	15	15q26.1	salivary gland mucoepidermoid	64784, CCDS32331.1, CRTC3, ENSG00000140577, FLJ21868, Q6DK61, Q6DK62, Q6UUV7, Q8TEF4, Q9H6U2, TORC3
CTNNB1	catenin (cadherin-associated protein), beta 1	1499	3	3p22-p21.3	colorectal, cvarian, hepatoblastoma, others, pleomorphic salivary adenoma	1499, CCDS2694.1, CTNNB, CTNNB1, ENSG00000168036, P35222
CYLD	familial cylindromatosis gene	1540	16	16q12-q13	cylindroma	1540, CDMT, CYLD, CYLD1, CYLDI, EAC, ENSG00000083799, FLJ20180, FLJ31664, HSPC057, KIAA0849, USPL2
D10S170	DNA segment on chromosome 10 (unique) 170, H4 gene (PTC1)	8030	10	10q21	papillary thyroid, CML
DAXX	death-domain associated protein	1616	6	6p21.3	Pancreatic neuroendocrine tumors. Paediatric GBM	1616, A2AB94, BING2, CCDS4776.1, DAP6, DAQB-126H3_2, DAXX, ENSG00000206206, MGC126245, MGC126246, Q4VX54, Q53F85, Q59FG7, Q5STK9, Q5STR5, Q9UER7
DDIT3	DNA-damage-inducible transcript 3	1649	12	12q13.1-q13.2	liposarcoma	1649, CCDS8943.1, CEBPZ, CHOP, CHOP10, DDIT3, ENSG00000175197, GADD153, MGC4154, P35638, Q53YD1, _C/EBP zeta_
DDX10	DEAD (Asp-Glu-Ala-Asp) box polypeptide 10	1662	11	11q22-q23	AML*	1662, CCDS8342.1, DDX10, ENSG00000178105, HRH-J8, Q13206, Q59EC7, Q86VR6
DDX5	DEAD (Asp-Glu-Ala-Asp) box polypeptide 5	1655	17	17q21	prostate	1655, CCDS11659.1, DDX5, DKFZp686J01190, ENSG00000108654, G17P1, HLR1, HUMP68, P17844, Q7Z2V5, p68
DDX6	DEAD (Asp-Glu-Ala-Asp) box polypeptide 6	1656	11	11q23.3	B-NHL	1656, DDX6, ENSG00000110367, FLJ36338, HLR2, P26196, P54, Q8IV96, RCK
DEK	DEK oncogene (DNA binding)	7913	6	6p23	AML	7913, CCDS34344.1, D6S231E, DEK, ENSG00000124795, P35659
DICER1	dicer 1, ribonuclease type III	23405	14	14q32.13	sex cord-stromal tumour, TGCT, embryonal rhadomyosarcoma	23405, CCDS9931.1, DICER1, Dicer, ENSG00000100697, HERNA, K12H4_8-LIKE, KIAA0928, Q5D0K4, Q5D0K5, Q9UFF3, Q9UPY3
DNM2	dynamin 2	1785	19	19p13.2	ETP ALL	1785, CCDS32907.1, CMTDI1, CMTDIB, DNM2, DYN2, DYNII, ENSG00000079805, Q9UPH5
DNMT3A	DNA (cytosine-5-)-methyltransferase 3 alpha	1788	2	2p23	AML	1788, CCDS33157.1, DNMT3A, DNMT3A2, ENSG00000119772, M_HsaIIIA, Q59HC6, Q6PJ37, Q86TE8, Q86XF5, Q8IZV0, Q8WVA9, Q9Y6K1
DUX4	double homeobox, 4	22947	4	4q35	soft tissue sarcoma	CCDS54828, DUX4, E0YLM6, F5GZ66, F8QWU0, F8QWU1, F8QWU2, P0CJ85, P0CJ86, P0CJ88, P0CJ89, P0CJ90, Q13060, Q14546, Q14547
EBF1	early B-cell factor 1	1879	5	5q34	lipoma	1879, CCDS4343.1, COE1, EBF, EBF1, ENSG00000164330, O/E-1, OLF1, Q9UH73
ECT2L	epithelial cell transforming sequence 2 oncogene-like	345930	6	6q24.1	ETP ALL	345930, C6orf91, CCDS43508.1, ECT2L, ENSG00000203734, LFDH, Q008S8, dJ509I19_2, dJ509I19_3
EGFR	epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)	1956	7	7p12.3-p12.1	glioma, NSCLC	1956, CCDS5514.1, EGFR, ENSG00000146648, ERBB, ERBB1, P00533, mENA
EIF4A2	eukaryotic translation initiation factor 4A, isoform 2	1974	3	3q27.3	NHL	1974, BM-010, CCDS3282.1, DDX2B, EIF4A, EIF4A2, EIF4F, ENSG00000156976
ELF4	E74-like factor 4 (ets domain transcription factor)	2000	X	Xq26	AML	2000, CCDS14617.1, ELF4, ELFR, ENSG00000102034, MEF, Q5H9H5, Q99607, RP3-510O21_2
ELK4	ELK4, ETS-domain protein (SRF accessory protein 1)	2005	1	1q32	prostate	2005, CCDS1456.1, ELK4, ENSG00000158711, P28324, Q8IXL1, SAP1
ELKS	ELKS protein	23085	12	12p13.3	papillary thyroid	23085, A2RU77, CCDS8508.1, Cast2, ELKS, ENSG00000082805, ERC1, KIAA108, KIAA1081, MGC12974, Q8IUD2, RAB6IP2
ELL	ELL gene (11-19 lysine-rich leukemia gene)	8178	19	19p13.1	AL	8178, C19orf17, CCDS12380.1, ELL, ELL1, ENSG00000105656, Men, P55199, Q59HG4, Q75MS0
ELN	elastin	2006	7	7q11.23	B-ALL	2006, CCDS5562.2, ELN, ENSG00000049540, FLJ38671, FLJ43523, Q9UMK5, SVAS, WBS, WS
EML4	echinoderm microtubule associated protein like 4	27436	2	2p21	NSCLC	27436, EML4, ENSG00000143924
EP300	300 kd E1A-Binding protein gene	2033	22	22q13	colorectal, breast, pancreatic, AML, ALL, DLBCL	2033, CCDS14010.1, ENSG00000100393, EP300, RP1-85F18_1, p300
EPS15	epidermal growth factor receptor pathway substrate 15 (AF1p)	2060	1	1p32	ALL	2060, AF-1P, AF1P, CCDS557.1, ENSG00000085832, EPS15, MLLT5, P42566
ERBB2	v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)	2064	17	17q21.1	breast, ovarian, other tumour types, NSCLC, gastric	2064, ENSG00000141736, ERBB2, HER-2, HER-2/neu, HER2, NEU, NGL, P04626, TKR1, c-erb B2, c-erbB2
ERG	v-ets erythroblastosis virus E26 oncogene like (avian)	2078	21	21q22.3	Ewing sarcoma, prostate, AML	2078, CCDS13657.1, ERG, P11308
ETV1	ets variant gene 1	2115	7	7p22	Ewing sarcoma, prostate	2115, DKFZp781L0674, ENSG00000006468, ER81, ETV1, MGC104699, MGC120533, MGC120534
ETV4	ets variant gene 4 (E1A enhancer binding protein, E1AF)	2118	17	17q21	Ewing sarcoma, Prostate carcinoma	2118, CCDS11465.1, E1A-F, E1AF, ENSG00000175832, ETV4, PEA3, PEAS3
ETV5	ets variant gene 5	2119	3	3q28	Prostate	2119, CCDS33906.1, ENSG00000244405, ERM, ETV5, P41161, Q6IBN5
ETV6	ets variant gene 6 (TEL oncogene)	2120	12	12p13	congenital fibrosarcoma, multiple leukemia and lymphoma, secretory breast, MDS, ALL	2120, CCDS8643.1, ENSG00000139083, ETV6, P41212, Q9UME7, TEL, TEL/ABL
EVI1	ecotropic viral integration site 1	2122	3	3q26	AML, CML	2122, A1L4F3, CCDS3205.1, ENSG00000085276, EVI1, MDS1-EVI1, MECOM, PRDM3, Q03112, Q5HYI1, Q6MZS6, Q8IU84, Q8NEI5
EWSR1	Ewing sarcoma breakpoint region 1 (EWS)	2130	22	22q12	Ewing sarcoma, desmoplastic small round cell tumor , ALL, clear cell sarcoma, sarcoma, myoepithelioma	2130, CCDS13851.1, ENSG00000182944, EWS, EWSR1
EZH2	enhancer of zeste homolog 2	2146	7	7q35-q36	DLBCL	2146, B2RAQ1, B3KS30, CCDS5891.1, CCDS5892, ENSG00000106462, ENX-1, ENX1, EZH1, EZH2, EZH2_ENST00000350995, KMT6, MGC9169, Q15910, Q6R125, Q75MG3, Q75MP9, Q75MQ0, Q96FI6
EZR	ezrin	7430	6	6q25.3	NSCLC	7430, CCDS5258.1, CVIL, CVL, DKFZp762H157, ENSG00000092820, EZR, FLJ26216, MGC1584, P15311, Q6NUR7, Q9UJZ2, Q9UJZ6, Q9UJZ7, Q9UJZ8, Q9UK20
FACL6	fatty-acid-coenzyme A ligase, long-chain 6	23305	5	5q31	AML, AEL	23305, ACS2, ACSL6, CCDS34228.1, ENSG00000164398, FACL6, KIAA0837, LACS2, LACS5
FAM22A	family with sequence similarity 22, member A	728118	10	10q23.2	edometrial stromal sarcoma	ENSG00000214562, FAM22A, FAM22D
FAM22B	family with sequence similarity 22, member B	729262	10	10q22.3	edometrial stromal sarcoma
FAM46C	family with sequence similarity 46, member C	54855	1	1p12	MM	54855, A3KMG2, CCDS896.1, ENSG00000183508, FAM46C, FLJ20202, Q5VWP2
FBXO11	F-box protein 11	80204	2	2p16.3	DLBCL	80204, A1L491, CCDS1837.1, ENSG00000138081, FBX11, FBXO11, FLJ12673, MGC44383, PRMT9, Q53RT5, Q86XK2, UG063H01, VIT1
FBXW7	F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila)	55294	4	4q31.3	colorectal, endometrial, T-ALL	55294, AGO, CCDS3777.1, CCDS3778.1, CDC4, DKFZp686F23254, ENSG00000109670, FBW7, FBX30, FBXW6, FBXW7, FBXW7_NM_018315_2, FLJ11071, SEL-10, SEL10
FCGR2B	Fc fragment of IgG, low affinity IIb, receptor for (CD32)	2213	1	1q23	ALL	2213, CCDS30924.1, CD32, CD32B, ENSG00000072694, FCG2, FCGR2, FCGR2B, IGFR2, P31994, Q8IU78, Q8IU79, Q8IXE8, Q8IXE9, Q8IZV7, Q8NI89, Q8NIA0
FEV	FEV protein - (HSRNAFEV)	54738	2	2q36	Ewing sarcoma	54738, CCDS2428.1, ENSG00000163497, FEV, HSRNAFEV, PET-1, Pet-1
FGFR1	fibroblast growth factor receptor 1	2260	8	8p11.2-p11.1	MPD, NHL	2260, BFGFR, CD331, CEK, ENSG00000077782, FGFBR, FGFR1, FLG, FLT2, H2, H3, H4, H5, HBGFR, KAL2, N-SAM, P11362
FGFR1OP	FGFR1 oncogene partner (FOP)	11116	6	6q27	MPD, NHL	11116, CCDS5297.1, ENSG00000213066, FGFR1OP, FOP
FGFR2	fibroblast growth factor receptor 2	2263	10	10q26	gastric. NSCLC, endometrial	2263, BEK, BFR-1, CD332, CEK3, CFD1, ECT1, ENSG00000066468, FGFR2, JWS, K-SAM, KGFR, TK14, TK25
FGFR3	fibroblast growth factor receptor 3	2261	4	4p16.3	bladder, MM, T-cell lymphoma	2261, ACH, CCDS3353.1, CD333, CEK2, ENSG00000068078, FGFR3, HSFGFR3EX, JTK4, P22607
FHIT	fragile histidine triad gene	2272	3	3p14.2	pleomorphic salivary gland adenoma	2272, A2IAS9, A2IAT6, AP3Aase, CCDS2894.1, ENSG00000189283, FHIT, FRA3B, O00298, P49789, Q0MQR8, Q0PUW1, Q194U8, Q194V0, Q1WAB3, Q45QG9, Q5G284, Q71VB2
FIP1L1	FIP1 like 1 (S. cerevisiae)	81608	4	4q12	idiopathic hypereosinophilic syndrome	81608, CCDS3491.1, DKFZp586K0717, ENSG00000145216, FIP1L1, Q6UN15
FLI1	Friend leukemia virus integration 1	2313	11	11q24	Ewing sarcoma	2313, ENSG00000151702, EWSR2, FLI1, Q01543, SIC-1
FLJ27352	BX648577, FLJ27352 hypothetical LOC145788	145788	15	15q21.3	PMBL, Hodgkin Lymphona,
FLT3	fms-related tyrosine kinase 3	2322	13	13q12	AML, ALL	2322, CD135, ENSG00000122025, FLK2, FLT3, P36888, RP11-153M24_3, STK1
FNBP1	formin binding protein 1 (FBP17)	23048	9	9q23	AML	8412, BCAR3, ENSG00000137936, FNBP1, KIAA0554, NSP2, SH2D3B
FOXL2	forkhead box L2	668	3	3q23	granulosa-cell tumour of the ovary	668, BPES, BPES1, CCDS3105.1, ENSG00000183770, FOXL2, P58012, PFRK, PINTO, POF3, Q05CX9, Q4JHB5, Q4JHB7, Q53ZD3
FOXO1A	forkhead box O1A (FKHR)	2308	13	13q14.1	alveolar rhabdomyosarcomas	2308, CCDS9371.1, ENSG00000150907, FKH1, FKHR, FOXO1, FOXO1A, Q12778
FOXO3A	forkhead box O3A	2309	6	6q21	AL	2309, AF6q21, CCDS5068.1, DKFZp781A0677, ENSG00000118689, FKHRL1, FKHRL1P2, FOXO2, FOXO3, FOXO3A, MGC12739, MGC31925, O43524, Q68DV3, Q9UPC2
FOXP1	forkhead box P1	27086	3	3p14.1	ALL	12CC4, 27086, CCDS2914.1, ENSG00000114861, FLJ23741, FOXP1, HSPC215, MGC12942, MGC88572, MGC99551, QRF1, hFKH1B
FSTL3	follistatin-like 3 (secreted glycoprotein)	10272	19	19p13	B-CLL	10272, CCDS12040.1, ENSG00000070404, FLRG, FSTL3, O95633
FUBP1	far upstream element (FUSE) binding protein 1	8880	1	1p13.1	oligodendroglioma	8880, CCDS683.1, ENSG00000162613, FBP, FUBP, FUBP1
FUS	fusion, derived from t(12;16) malignant liposarcoma	2521	16	16p11.2	liposarcoma, AML, Ewing sarcoma, angiomatoid fibrous histiocytoma, fibromyxoid sarcoma	2521, CCDS10707.1, CHOP, ENSG00000089280, FUS, FUS-CHOP, FUS1, P35637, Q13344, Q6IBQ5, Q8TBR3, TLS, TLS/CHOP
FVT1	follicular lymphoma variant translocation 1	2531	18	18q21.3	B-NHL	2531, CCDS11982.1, ENSG00000119537, FVT1, KDSR, Q06136
GAS7	growth arrest-specific 7	8522	17	17p	AML*	8522, CCDS11152.1, ENSG00000007237, GAS7, KIAA0394, MGC1348, MLL/GAS7, O60861, Q29RX5, Q53Y77, Q59GS9, Q7Z571
GATA1	GATA binding protein 1 (globin transcription factor 1)	2623	X	Xp11.23	megakaryoblastic leukemia of Downs Syndrome	2623, CCDS14305.1, ENSG00000102145, ERYF1, GATA1, GF1, NFE1, P15976
GATA2	GATA binding protein 2	2624	3	3q21.3	AML(CML blast transformation)	2624, CCDS3049.1, ENSG00000179348, GATA2, MGC2306, NFE1B, P23769, Q53YE0, Q96BH0, Q96BH8
GATA3	GATA binding protein 3	2625	10	10p15	breast	2625, CCDS31143.1, ENSG00000107485, GATA3, HDR, MGC2346, MGC5199, MGC5445, Q5VWG7
GMPS	guanine monphosphate synthetase	8833	3	3q24	AML	8833, ENSG00000163655, GMPS
GNA11	guanine nucleotide binding protein (G protein), alpha 11 (Gq class)	2767	19	19p13.3	uveal melanoma	2767, CCDS12103.1, ENSG00000088256, GNA-11, GNA11
GNAQ	guanine nucleotide binding protein (G protein), q polypeptide	2776	9	9q21	uveal melanoma	2776, CCDS6658.1, ENSG00000156052, G-ALPHA-q, GAQ, GNAQ, P50148, Q5T8F3, Q6NT27, RP11-494N1_1
GNAS	guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1	2778	20	20q13.2	pituitary adenoma	2778, AHO, C20orf45, CCDS13471.1, ENSG00000087460, GNAS, GNAS1, GNASXL, GNAS_NM_016592_1, GPSA, GSA, GSP, Gnas, MGC33735, NESP, NESP55, PHP1A, PHP1B, POH, RP4-543J19_4, SCG6, XL, XL2, XLalphas, dJ309F20_1_1, dJ806M20_3_3
GOLGA5	golgi autoantigen, golgin subfamily a, 5 (PTC5)	9950	14	14q	papillary thyroid	9950, CCDS9905.1, ENSG00000066455, GOLGA5, Q2TS49, Q8TBA6, golgin-84, ret-II, rfg5
GOPC	golgi associated PDZ and coiled-coil motif containing	57120	6	6q21	glioblastoma	57120, CAL, CCDS5117.1, ENSG00000047932, FIG, GOPC, GOPC1, Q9HD26, dJ94G16_2 PIST
GPHN	gephyrin (GPH)	10243	14	14q24	AL	10243, CCDS9777.1, ENSG00000171723, GPHN
GRAF	GTPase regulator associated with focal adhesion kinase pp125(FAK)	23092	5	5q31	AML, MDS	23092, ARHGAP26, ENSG00000145819, FLJ42530, GRAF, KIAA0621, OPHN1L, OPHN1L1
H3F3A	H3 histone, family 3A	3020	1	1q42.12	glioma	3020, CCDS1550.1, ENSG00000163041, H3F3, H3F3A, H3_3A, H3_3B, LOC347376, MGC87782, MGC87783, P84243, Q6TXQ4
HCMOGT-1	sperm antigen HCMOGT-1	92521	17	17p11.2	JMML	92521, CCDS32590.1, CYTSB, ENSG00000128487, FLJ36955, HCMOGT-1, NSP, Q5M775, SPECC1
HEAB	ATP_GTP binding protein	10978	11	11q12	AML	10978, CCDS7964.1, CLP1, ENSG00000172409, HEAB, Q92989, hClp1
HERPUD1	homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1	9709	16	16q12.2-q13	prostate	9709, A4UAE9, CCDS10771.1, ENSG00000051108, HERP, HERPUD1, KIAA0025, Mif1, Q15011, Q53FP9, Q6IAN8, Q9HBR2, SUP
HEY1	hairy/enhancer-of-split related with YRPW motif 1	23462	8	8q21	mesenchymal chondrosarcoma	23462, CCDS6225.1, CHF-2, CHF2, ENSG00000164683, HERP2, HESR-1, HESR1, HEY1, HRT-1, MGC1274, OAF1
HIP1	huntingtin interacting protein 1	3092	7	7q11.23	CMML	3092, ENSG00000127946, HIP1, ILWEQ, Q8TDA4
HIST1H4I	histone 1, H4i (H4FM)	8294	6	6p21.3	NHL	8294, CCDS4620.1, HIST1H4I, HIST4H4, MGC24116, P62805, Q0VAS5, Q6B823, Q6DRA9, Q6FGB8, Q6NWP7
HLF	hepatic leukemia factor	3131	17	17q22	ALL	3131, CCDS11585.1, ENSG00000108924, HLF, Q16534, Q6FHS9
HLXB9	homeo box HB9	3110	7	7q36	AML	3110, CCDS34788.1, ENSG00000130675, HB9, HLXB9, MNX1, P50219, Q9UDY3
HMGA1	high mobility group AT-hook 1	3159	6	6p21	microfollicular thyroid adenoma, various benign mesenchymal tumors,	3159, CCDS4789.1, ENSG00000137309, HMG-R, HMGA1, HMGIY, MGC12816, MGC4242, MGC4854, P17096, Q5T6U9
HMGA2	high mobility group AT-hook 2 (HMGIC)	8091	12	12q15	lipoma, leiomyoma, pleiomorphic salivary gland adenoma	8091, BABL, ENSG00000149948, HMGA2, HMGI-C, HMGIC, LIPO
HNRNPA2B1	heterogeneous nuclear ribonucleoprotein A2/B1	3181	7	7p15	prostate	3181, CCDS5397.1, ENSG00000122566, HNRNPA2, HNRNPA2B1, HNRNPB1, HNRPA2, HNRPB1, RNPA2, SNRPB1
HOOK3	hook homolog 3	84376	8	8p11.21	papillary thyroid	84376, CCDS6139.1, ENSG00000168172, HK3, HOOK3, Q86VS8
HOXA11	homeo box A11	3207	7	7p15-p14.2	CML	3207, CCDS5411.1, ENSG00000005073, HOX1, HOX1I, HOXA11, P31270
HOXA13	homeo box A13	3209	7	7p15-p14.2	AML	3209, CCDS5412.1, ENSG00000106031, HOX1, HOX1J, HOXA13, P31271, Q6DI00
HOXA9	homeo box A9	3205	7	7p15-p14.2	AML*	3205, CCDS5409.1, ENSG00000078399, HOX1, HOX1G, HOXA9, P31269
HOXC11	homeo box C11	3227	12	12q13.3	AML	3227, CCDS8867.1, ENSG00000123388, HOX3H, HOXC11, O43248
HOXC13	homeo box C13	3229	12	12q13.3	AML	3229, CCDS8865.1, ENSG00000123364, HOX3, HOX3G, HOXC13, P31276, Q6LAM3
HOXD11	homeo box D11	3237	2	2q31-q32	AML	3237, CCDS2265.1, ENSG00000128713, HOXD11
HOXD13	homeo box D13	3239	2	2q31-q32	AML*	3239, CCDS2264.1, HOX4I, HOXD13, P35453, SPD
HRAS	v-Ha-ras Harvey rat sarcoma viral oncogene homolog	3265	11	11p15.5	infrequent sarcomas, rare other types	3265, CCDS7698.1, ENSG00000174775, HRAS, HRAS1, K-ras, N-ras, P01112, RASH1, c-bas/has
HRPT2	hyperparathyroidism 2	3279	1	1q21-q31	parathyroid adenoma	79577, C1orf28, CCDS1382.1, CDC73, ENSG00000134371, FLJ23316, HPT-JT, HRPT2, Q6P1J9, Q6PHR8
HSPCA	heat shock 90kDa protein 1, alpha	3320	14	14q32.31	NHL	3320, CCDS32160.1, ENSG00000080824, FLJ31884, HSP86, HSP90A, HSP90AA1, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp89, Hsp90, LAP2, O75322, P07900, Q14568, Q2VPJ6, Q5CAQ6, Q5CAQ7, Q86SX1, Q86U12, Q8TBA7, Q96HX7
HSPCB	heat shock 90kDa protein 1, beta	3326	6	6p12	NHL	3326, CCDS4909.1, D6S182, ENSG00000096384, FLJ26984, HSP90-BETA, HSP90AB1, HSP90B, HSPC2, HSPCB, P08238, Q6PK50, Q9H6X9
IDH1	isocitrate dehydrogenase 1 (NADP+), soluble	3417	2	2q33.3	gliobastoma	3417, CCDS2381.1, ENSG00000138413, IDH, IDH1, IDP, O75874, PICD, Q0QER2, Q567U4, Q6FHQ6, Q6FI37, Q6FIA4, Q7Z3V0
IDH2	socitrate dehydrogenase 2 (NADP+), mitochondrial	3418	15	15q26.1	GBM	3418, CCDS10359.1, ENSG00000182054, ICD-M, IDH, IDH2, IDHM, IDP, P48735, Q53GL5, mNADP-IDH
IGH@	immunoglobulin heavy locus	3492	14	14q32.33	MM, Burkitt lymphoma, NHL, CLL, B-ALL, MALT, MLCLS
IGK@	immunoglobulin kappa locus	50802	2	2p12	Burkitt lymphoma, B-NHL
IGL@	immunoglobulin lambda locus	3535	22	22q11.1-q11.2	Burkitt lymphoma
IKZF1	IKAROS family zinc finger 1	10320	7	7p12.2	ALL, DLBCL	10320, ENSG00000185811, Hs_54452, IKAROS, IKZF1, LyF-1, Q13422, ZNFN1A1, hIk-1
IL2	interleukin 2	3558	4	4q26-q27	intestinal T-cell lymphoma	3558, CCDS3726.1, ENSG00000109471, IL-2, IL2, P60568, Q0GK43, Q13169, Q16334, Q309Q7, Q6NZ91, Q6NZ93, Q6QWN0, Q71V48, Q7Z7M3, Q8NFA4, Q9C001
IL21R	interleukin 21 receptor	50615	16	16p11	NHL	50615, CCDS10630.1, ENSG00000103522, IL21R, Q9HBE5
IL6ST	interleukin 6 signal transducer (gp130, oncostatin M receptor)	3572	5	5q11	hepatocellular ca	3572, A0N0L4, CCDS3971.1, CD130, CDw130, ENSG00000134352, GP130, GP130-RAPS, IL6R-beta, IL6ST, P40189, Q17RA0
IL7R	interleukin 7 receptor	146661	5	5p13	ALL, ETP ALL	3575, CCDS3911.1, CD127, CDW127, ENSG00000168685, IL-7R-alpha, IL7R, P16871, Q05CU8, Q6NSP4, Q6NWM0, Q6NWM1, Q6NWM2, Q6NWM3
IRF4	interferon regulatory factor 4	3662	6	6p25-p23	MM	3662, CCDS4469.1, ENSG00000137265, IRF4, LSIRF, MUM1, Q15306
IRTA1	immunoglobulin superfamily receptor translocation associated 1	83417	1	1q21	B-NHL	83417, CCDS1166.1, ENSG00000163518, FCRH4, FCRL4, IGFP2, IRTA1, Q96PJ5, Q96RE0
ITK	IL2-inducible T-cell kinase	3702	5	5q31-q32	peripheral T-cell lymphoma	3702, CCDS4336.1, EMT, ENSG00000113263, ITK, LYK, MGC126257, MGC126258, PSCTK2, Q08881
JAK1	Janus kinase 1	3716	1	1p32.3-p31.3	ALL	3716, CCDS41346, ENSG00000162434, JAK1, JAK1A, JAK1B, JAK1_ENST00000342505, JTK3, P23458, Q0VGA4, Q4LDX3, Q6P669, Q8IV82
JAK2	Janus kinase 2	3717	9	9p24	ALL, AML, MPD, CML	3717, A8K910, A9QVL8, B4DYV1, CCDS6457, ENSG00000096968, JAK2, JAK2_ENST00000381652, JTK10, O60674, Q506Q0, Q52R86, Q8IXP2
JAK3	Janus kinase 3	3718	19	19p13.1	acute megakaryocytic leukemia, ETP ALL	3718, CCDS12366.1, ENSG00000105639, JAK-3, JAK3, JAK3_HUMAN, JAKL, L-JAK, LJAK, P52333
JAZF1	juxtaposed with another zinc finger gene 1	221895	7	7p15.2-p15.1	endometrial stromal tumours	221895, CCDS5416.1, ENSG00000153814, JAZF1, Q69YN3, Q86VZ6
JUN	jun oncogene	3725	1	1p32-p31	sarcoma	3725, AP1, CCDS610.1, ENSG00000177606, JUN, P05412, Q6FHK0, Q6FHM7, c-Jun
KDM5A	lysine (K)-specific demethylase 5A, JARID1A	5927	12	12p11	AML	5927, ENSG00000073614, JARID1A, KDM5A, RBBP2, RBP2
KDM5C	lysine (K)-specific demethylase 5C (JARID1C)	8242	X	Xp11.22-p11.21	clear cell renal carcinoma	8242, DXS1272E, ENSG00000126012, JARID1C, KDM5C, MRXJ, MRXSJ, RP11-258C19_2, SMCX, XE169
KDM6A	lysine (K)-specific demethylase 6A, UTX	7403	X	Xp11.2	renal, oesophageal SCC, MM	7403, CCDS14265.1, DKFZp686A03225, ENSG00000147050, KDM6A, MGC141941, O15550, Q52LL9, Q590H7, Q59HG3, Q5JV43, Q68D33, Q6N053, RP13-886N14_3, UTX, bA386N14_2
KDR	vascular endothelial growth factor receptor 2	3791	4	4q11-q12	NSCLC, angiosarcoma	3791, CCDS3497.1, CD309, ENSG00000128052, FLK1, KDR, P35968, VEGFR, VEGFR2
KIAA1549	KIAA1549	57670	7	7q34	pilocytic astrocytoma	57670, ENSG00000122778, KIAA1549
KIF5B	kinesin family member 5B	3799	10	10p11.22	NSCLC	3799, CCDS7171.1, ENSG00000170759, KIF5B, KINH, KNS, KNS1, P33176, Q2TA90, Q66K46, Q6P164, UKHC
KIT	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog	3815	4	4q12	GIST, AML, TGCT, mastocytosis, mucosal melanoma	3815, C-Kit, CD117, ENSG00000157404, KIT, P10721, SCFR
KLK2	kallikrein-related peptidase 2	3817	19	19q13.41	prostate	3817, CCDS12808.1, ENSG00000167751, KLK2, KLK2A2, MGC12201, P20151, Q6T775, hK2
KRAS	v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog	3845	12	12p12.1	pancreatic, colorectal, lung, thyroid, AML, others	3845, C-K-RAS, CCDS8702.1, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS, KRAS1, KRAS2, NS3, P01116, RASK2
KTN1	kinectin 1 (kinesin receptor)	3895	14	14q22.1	papillary thryoid	3895, CCDS9725.1, CG1, ENSG00000126777, KIAA0004, KTN1, Q17RZ5, Q3SWV9, Q5GGW3, Q6NZ46, Q6PDF7, Q86UP2
LAF4	lymphoid nuclear protein related to AF4	3899	2	2q11.2-q12	ALL, T-ALL	3899, AFF3, CCDS33258.1, ENSG00000144218, LAF4, MLLT2-like, P51826
LASP1	LIM and SH3 protein 1	3927	17	17q11-q21.3	AML	3927, CCDS11331.1, ENSG00000002834, LASP1, Lasp-1, MLN50, Q14847
LCK	lymphocyte-specific protein tyrosine kinase	3932	1	1p35-p34.3	T-ALL	3932, ENSG00000182866, LCK, P06239, YT16, p56lck, pp58lck
LCP1	lymphocyte cytosolic protein 1 (L-plastin)	3936	13	13q14.1-q14.3	NHL	3936, CCDS9403.1, CP64, DKFZp781A23186, ENSG00000136167, FLJ25423, FLJ26114, FLJ39956, L-PLASTIN, LC64P, LCP1, P13796, PLS2, Q53FI1, Q59GX5, Q5TBN3, Q5TBN4, Q5TBN5
LCX	leukemia-associated protein with a CXXC domain	80312	10	10q21	AML	80312, CCDS7281.1, CXXC6, ENSG00000138336, KIAA1676, LCX, Q8NFU7, TET1, bA119F7_1
LHFP	lipoma HMGIC fusion partner	10186	13	13q12	lipoma	10186, CCDS9369.1, ENSG00000183722, LHFP, MGC22429
LIFR	leukemia inhibitory factor receptor	3977	5	5p13-p12	salivary adenoma	3977, CCDS3927.1, CD118, ENSG00000113594, LIFR, SJS2, STWS, SWS
LMO1	LIM domain only 1 (rhombotin 1) (RBTN1)	4004	11	11p15	T-ALL, neuroblastoma	4004, ENSG00000166407, LMO1, P25800, Q8IXR0, RBTN1, RHOM1, TTG1
LMO2	LIM domain only 2 (rhombotin-like 1) (RBTN2)	4005	11	11p13	T-ALL	4005, CCDS7888.1, ENSG00000135363, LMO2, P25791, RBTN2, RBTNL1, RHOM2, TTG2
LPP	LIM domain containing preferred translocation partner in lipoma	4026	3	3q28	lipoma, leukemia	4026, A1L4L6, CCDS3291.1, ENSG00000145012, LPP, Q93052
LRIG3	leucine-rich repeats and immunoglobulin-like domains 3	121227	12	12q14.1	NSCLC	121227, CCDS8960.1, ENSG00000139263, FLJ26573, FLJ90440, KIAA3016, LRIG3, Q6UXM1
LYL1	lymphoblastic leukemia derived sequence 1	4066	19	19p13.2-p13.1	T-ALL	4066, CCDS12292.1, ENSG00000104903, LYL1, P12980
MADH4	Homolog of Drosophila Mothers Against Decapentaplegic 4 gene	4089	18	18q21.1	colorectal, pancreatic, small intestine	4089, CCDS11950.1, DPC4, ENSG00000141646, JIP, MADH4, Q13485, Q9BYG6, SMAD4
MAF	v-maf musculoaponeurotic fibrosarcoma oncogene homolog	4094	16	16q22-q23	MM	4094, CCDS10928.1, ENSG00000178573, MAF, MGC71685
MAFB	v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian)	9935	20	20q11.2-q13.1	MM	9935, CCDS13311.1, ENSG00000204103, KRML, MAFB, MGC43127, Q9Y5Q3
MALT1	mucosa associated lymphoid tissue lymphoma translocation gene 1	10892	18	18q21	MALT	10892, CCDS11968.1, ENSG00000172175, MALT1
MAML2	mastermind-like 2 (Drosophila)	84441	11	11q22-q23	salivary gland mucoepidermoid	84441, DKFZp686N0150, ENSG00000184384, KIAA1819, MAM-3, MAM2, MAM3, MAML2, MLL-MAML2, Q8IZL2
MAP2K4	mitogen-activated protein kinase kinase 4	6416	17	17p11.2	pancreatic, breast, colorectal	6416, CCDS11162.1, ENSG00000065559, JNKK, JNKK1, MAP2K4, MAPKK4, MEK4, MKK4, P45985, PRKMK4, SEK1, SERK1
MDM2	Mdm2 p53 binding protein homolog	4193	12	12q15	sarcoma, glioma, colorectal, other	4193, CCDS8986.1, ENSG00000135679, HDM2, HDMX, MDM2, MGC71221, Q00987, Q546E6, Q8NDV9, Q8WYJ3, Q96DS4, hdm2
MDM4	Mdm4 p53 binding protein homolog	4194	1	1q32	GBM, bladder, retinoblastoma	4194, CCDS1447.1, DKFZp781B1423, ENSG00000198625, MDM4, MDMX, MGC132766, MRP1, RP11-430C7_1
MDS1	myelodysplasia syndrome 1	4197	3	3q26	MDS, AML	4197, MDS1, MDS1-EVI1, PRDM3, Q13465, Q6FH90
MDS2	myelodysplastic syndrome 2	259283	1	1p36	MDS	259283, ENSG00000197880, MDS2, Q8NDY4
MECT1	mucoepidermoid translocated 1	94159	19	19p13	salivary gland mucoepidermoid	23373, CCDS32963.1, CRTC1, ENSG00000105662, FLJ14027, KIAA0616, MECT1, Q6UUV9, TORC1, WAMTP1
MED12	mediator complex subunit 12	9968	X	Xq13	uterine leiomyoma	9968, ARC240, CAGH45, CCDS43970, FGS1, HOPA, KIAA0192, MED12, MED12_ENST00000374080, OKS, OPA1, Q7Z2E0, Q7Z2F1, Q7Z2F4, Q93074, TNRC11, TRAP230
MEN1	multiple endocrine neoplasia type 1 gene	4221	11	11q13	parathyroid tumors, Pancreatic neuroendocrine tumors	4221, CCDS31600.1, ENSG00000133895, MEN1, Q9BUF0, Q9GZQ5, Q9UE24
MET	met proto-oncogene (hepatocyte growth factor receptor)	4233	7	7q31	papillary renal, head-neck squamous cell	4233, AUTS9, ENSG00000105976, HGFR, MET, P08581, RCCP2
MITF	microphthalmia-associated transcription factor	4286	3	3p14.1	melanoma	4286, CCDS2913.1, ENSG00000187098, MITF, WS2A
MKL1	megakaryoblastic leukemia (translocation) 1	57591	22	22q13	acute megakaryocytic leukemia	57591, A4FUJ8, BSAC, CCDS14003.1, ENSG00000196588, MAL, MKL1, MRTF-A, Q29R68, Q969V6
MLF1	myeloid leukemia factor 1	4291	3	3q25.1	AML	4291, CCDS3182.1, ENSG00000178053, MLF1, P58340, Q2TLE3, Q2TLE4
MLH1	E.coli MutL homolog gene	4292	3	3p21.3	colorectal, endometrial, ovarian, CNS	4292, CCDS2663.1, COCA2, ENSG00000076242, FCC2, HNPCC, HNPCC2, MGC5172, MLH1, P40692, Q0ZAJ3, Q0ZAJ6, Q53GX1, Q5GJ64, Q64FK0, Q6VBB8, hMLH1
MLL	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)	4297	11	11q23	AML, ALL	4297, ALL-1, CXXC7, ENSG00000118058, HRX, HTRX1, MLL, MLL/GAS7, MLL1A, TRX1
MLL2	myeloid/lymphoid or mixed-lineage leukemia 2	8085	12	12q12-q14	medulloblastoma, renal	8085, ENSG00000167548, MLL2
MLL3	myeloid/lymphoid or mixed-lineage leukemia 3	58508	7	7q36.1	medulloblastoma	58508, ENSG00000055609, MLL3
MLLT1	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1 (ENL)	4298	19	19p13.3	AL	4298, CCDS12160.1, ENL, ENSG00000130382, LTG19, MLLT1, Q03111, YEATS1
MLLT10	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 (AF10)	8028	10	10p12	AL	8028, AF10, CCDS7135.1, ENSG00000078403, MLLT10, O60696, P55197, Q59EQ6, Q71UR7
MLLT2	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 2 (AF4)	4299	4	4q21	AL	4299, AF-4, AFF1, CCDS3616.1, ENSG00000172493, MLLT2, P51825, PBM1, Q05D98, Q14C88, Q6LA76, Q712L1
MLLT3	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 (AF9)	4300	9	9p22	ALL	4300, AF-9, AF9, CCDS6494.1, ENSG00000171843, MLLT3, P42568, Q5VV08, Q5VV09, Q6LEQ8, Q6MZE2, Q8IVB0, YEATS3
MLLT4	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 (AF6)	4301	6	6q27	AL	4301, CCDS5303.1, ENSG00000130396, MLLT4, Q5TIG7, Q5TIH1, Q96C95
MLLT6	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 (AF17)	4302	17	17q21	AL	4302, AF17, CCDS11327.1, ENSG00000108292, MLLT6, P55198, Q59F28, Q96IU3, Q9H5F6
MLLT7	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 7 (AFX1)	4303	X	Xq13.1	AL	4303, AFX1, ENSG00000184481, FOXO4, MLLT7, P98177
MN1	meningioma (disrupted in balanced translocation) 1	4330	22	22q13	AML, meningioma	4330, A5HML1, A9Z1V9, CCDS42998.1, ENSG00000169184, MGCR, MGCR1, MGCR1-PEN, MN1, Q10571, dJ353E16_2
MPL	myeloproliferative leukemia virus oncogene, thrombopoietin receptor	4352	1	p34	MPD	4352, C-MPL, CCDS483.1, CD110, ENSG00000117400, MPL, MPLV, P40238, Q308M1, Q5JUZ0, RP1-92O14_1, TPOR
MSF	MLL septin-like fusion	10801	17	17q25	AML*	10801, AF17q25, ENSG00000184640, KIAA0991, MSF, MSF1, NAPB, PNUTL4, SEPT9, SINT1, SeptD1
MSH2	mutS homolog 2 (E. coli)	4436	2	2p22-p21	colorectal, endometrial, ovarian	4436, CCDS1834.1, COCA1, ENSG00000095002, FCC1, HNPCC, HNPCC1, MSH2, P43246, Q0ZAI9, Q0ZAJ1, Q53FK0, Q53GS1, Q53RU4, Q6VBB7
MSH6	mutS homolog 6 (E. coli)	2956	2	2p16	colorectal	2956, CCDS1836.1, ENSG00000116062, GTBP, HNPCC5, HSAP, MSH6, P52701, Q1L838, Q3SWU9
MSI2	musashi homolog 2 (Drosophila)	124540	17	17q23.2	CML	124540, CCDS11597.1, ENSG00000153944, MSI2
MSN	moesin	4478	X	Xq11.2-q12	ALCL	4478, CCDS14382.1, ENSG00000147065, MSN, P26038, Q6PJT4
MTCP1	mature T-cell proliferation 1	4515	X	Xq28	T cell prolymphocytic leukemia	4515, C6_1B, ENSG00000214827, GS1-273L24_4, MTCP1
MUC1	mucin 1, transmembrane	4582	1	1q21	B-NHL	4582, CCDS1098.1, CD227, EMA, ENSG00000185499, H23AG, MAM6, MUC1, PEM, PEMT, PUM, Q14877, Q4VX39, Q7Z545
MYB	v-myb myeloblastosis viral oncogene homolog	4602	6	6q22-23	adenoid cystic carcinoma	4602, CCDS5174.1, Cmyb, ENSG00000118513, MYB, MYB_ENST00000341911, P10242, Q5THS4, Q5THS5, Q708E1, Q708E3, Q708E4, Q708E5, Q708E7, Q708E9, Q708J0, Q9UMI7, c-myb, c-myb_CDS, efg
MYC	v-myc myelocytomatosis viral oncogene homolog (avian)	4609	8	8q24.12-q24.13	Burkitt lymphoma, amplified in other cancers, B-CLL	4609, ENSG00000136997, MYC, c-Myc
MYCL1	v-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma derived (avian)	4610	1	1p34.3	small cell lung	4610, ENSG00000116990, LMYC, MYCL, MYCL1
MYCN	v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)	4613	2	2p24.1	neuroblastoma	4613, CCDS1687.1, ENSG00000134323, MODED, MYCN, N-myc, NMYC, ODED
MYD88	myeloid differentiation primary response gene (88)	4615	3	3p22	ABC-DLBCL	4615, B4DKU4, B4DU08, B4E3D6, CCDS2674, MYD88, MYD88D, MYD88_ENST00000396334, Q99836
MYH11	myosin, heavy polypeptide 11, smooth muscle	4629	16	16p13.13-p13.12	AML	4629, CCDS10566.1, ENSG00000133392, MYH11, O14729, Q16085, Q3MIV8, Q3MNF0, Q4G140, Q68D89, Q7Z7R0
MYH9	myosin, heavy polypeptide 9, non-muscle	4627	22	22q13.1	ALCL	4627, CCDS13927.1, DFNA17, ENSG00000100345, MYH9, P35579, Q2PS10, Q60FE2, Q86XU5, Q99529, Q9UMJ0
MYST4	MYST histone acetyltransferase (monocytic leukemia) 4 (MORF)	23522	10	10q22	AML	23522, CCDS7345.1, DKFZp313G1618, ENSG00000156650, FLJ90335, KIAA0383, MORF, MOZ2, MYST4, Q8WYB5, qkf, querkopf
NACA	nascent-polypeptide-associated complex alpha polypeptide	4666	12	12q23-q24.1	NHL	4666, CCDS31837.1, ENSG00000196531, FKSG17, HSD48, MGC117224, NACA, NACA1, NACAP1, Q13765, Q9BZK3
NCOA1	nuclear receptor coactivator 1	8648	2	2p23	alveolar rhadomyosarcoma	8648, CCDS1712.1, ENSG00000084676, F-SRC-1, MGC129719, MGC129720, NCOA1, NCoA-1, RIP160, SRC1
NCOA2	nuclear receptor coactivator 2 (TIF2)	10499	8	8q13.1	AML, Chondrosarcoma	10499, ENSG00000140396, GRIP1, MGC138808, NCOA2, NCoA-2, TIF2
NCOA4	nuclear receptor coactivator 4 - PTC3 (ELE1)	8031	10	10q11.2	papillary thyroid	8031, ARA70, CCDS7237.1, DKFZp762E1112, ELE1, ENSG00000138293, NCOA4, PTC3, Q13772, Q5T1E8, RFG, RP11-481A12_4
NDRG1	N-myc downstream regulated 1	10397	8	8q24.3	prostate	10397, CAP43, CCDS34945.1, CMT4D, DRG1, ENSG00000104419, GC4, HMSNL, NDR1, NDRG1, NMSL, PROXY1, Q53EU7, Q597H1, Q6IBG2, Q92597, Q9BRH7, RIT42, RTP, TARG1, TDD5
NF1	neurofibromatosis type 1 gene	4763	17	17q12	neurofibroma, glioma	4763, ENSG00000196712, NF1, NFNS, P21359, Q14931, Q4W6X4, Q7Z3J5, Q9UMU3
NF2	neurofibromatosis type 2 gene	4771	22	22q12.2	meningioma, acoustic neuroma, renal	4771, ACN, BANF, CCDS13861.1, ENSG00000186575, Merlin, NF2, P35240, Q9NRW8, SCH
NFE2L2	nuclear factor (erythroid-derived 2)-like 2 (NRF2)	4780	2	2q31	NSCLC, HNSCC	4780, CCDS42782.1, ENSG00000116044, NFE2L2, NRF2, Q16236, Q9BZF8
NFIB	nuclear factor I/B	4781	9	9p24.1	adenoid cystic carcinoma, lipoma	4781, CCDS6474.1, ENSG00000147862, NFI-RED, NFIB, NFIB2, NFIB3, NFIB_ENST00000397581, Q5VW26, RP11-280O24_2
NFKB2	nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)	4791	10	10q24	B-NHL	4791, A8K9D9, CCDS41565.1, ENSG00000077150, LYT-10, LYT10, NFKB2
NIN	ninein (GSK3B interacting protein)	51199	14	14q24	MPD	51199, CCDS32078.1, ENSG00000100503, KIAA1565, NIN
NKX2-1	NK2 homeobox 1	7080	14	14q13	NSCLC	7080, BCH, BHC, CCDS9659.1, ENSG00000136352, NK-2, NKX2-1, NKX2A, NKX2_1, O14956, P43699, Q7KZF6, TEBP, TITF1, TTF-1, TTF1
NONO	non-POU domain containing, octamer-binding	4841	X	Xq13.1	papillary renal cancer	4841, CCDS14410.1, ENSG00000147140, NMT55, NONO, NRB54, P54, P54NRB, Q15233
NOTCH1	Notch homolog 1, translocation-associated (Drosophila) (TAN1)	4851	9	9q34.3	T-ALL	4851, ENSG00000148400, NOTCH1, P46531, Q59ED8, Q5SXM3, TAN1, hN1
NOTCH2	Notch homolog 2	4853	1	1p13-p11	marginal zone lymphoma, DLBCL	4853, AGS2, CCDS908.1, ENSG00000134250, NOTCH2, Q04721, Q13560, Q5VTD0, Q6IQ50, Q96JU8, Q9UFD5, hN2
NPM1	nucleophosmin (nucleolar phosphoprotein B23, numatrin)	4869	5	5q35	NHL, APL, AML	4869, B23, CCDS4376.1, ENSG00000181163, MGC104254, NPM, NPM1, P06748
NR4A3	nuclear receptor subfamily 4, group A, member 3 (NOR1)	8013	9	9q22	extraskeletal myxoid chondrosarcoma	8013, A2A3I7, CCDS6742.1, CHN, CSMF, ENSG00000119508, MINOR, NOR1, NR4A3, Q92570, TEC
NRAS	neuroblastoma RAS viral (v-ras) oncogene homolog	4893	1	1p13.2	melanoma, MM, AML, thyroid	4893, ENSG00000213281, N-ras, NRAS, NRAS1, P01111
NSD1	nuclear receptor binding SET domain protein 1	64324	5	5q35	AML	64324, ARA267, CCDS4412.1, DKFZp666C163, ENSG00000165671, FLJ22263, FLJ44628, NSD1, Q658U6, Q8NB95, Q96DQ7, Q96L73, Q96MN8, Q9H6B5, Q9H6H8, SOTOS, STO
NTRK1	neurotrophic tyrosine kinase, receptor, type 1	4914	1	1q21-q22	papillary thyroid	4914, CCDS1161.1, DKFZp781I14186, ENSG00000198400, MTC, NTRK1, P04629, TRK, TRK1, TRKA, p140-TrkA
NTRK3	neurotrophic tyrosine kinase, receptor, type 3	4916	15	15q25	congenital fibrosarcoma, Secretory breast	4916, CCDS10340.1, ENSG00000140538, NTRK3, Q16288, TRKC, gp145(trkC)
NUMA1	nuclear mitotic apparatus protein 1	4926	11	11q13	APL	4926, CCDS31633.1, ENSG00000137497, NUMA, NUMA1, Q14980, Q3SYK8, Q4LE64, Q86XH4, Q9UNL7, Q9UPG3
NUP214	nucleoporin 214kDa (CAN)	8021	9	9q34.1	AML, T-ALL	8021, CAIN, CAN, CCDS6940.1, D9S46E, ENSG00000126883, MGC104525, N214, NUP214, P35658, Q3KQZ0, Q5JUP7, Q5JUP9, Q75R47, Q7Z3C4, Q86XD3, RP11-544A12_7
NUP98	nucleoporin 98kDa	4928	11	11p15	AML	4928, ADIR2, CCDS7746.1, ENSG00000110713, NUP196, NUP98
OLIG2	oligodendrocyte lineage transcription factor 2 (BHLHB1)	10215	21	21q22.11	T-ALL	10215, BHLHB1, CCDS13620.1, ENSG00000205927, OLIG2, OLIGO2, PRKCBP2, RACK17
OMD	osteomodulin	4958	9	9q22.31	aneurysmal bone cysts	4958, CCDS6696.1, ENSG00000127083, OMD, Q5TBF4, Q99983, SLRR2C, osteoadherin
P2RY8	purinergic receptor P2Y, G-protein coupled, 8	286530	X,Y	Xp22.3; Yp11.3	B-ALL, Downs associated ALL	286530, CCDS14115.1, ENSG00000182162, MGC50878, P2RY8, P2Y8, Q86VZ1, RP11-261P4_4
PAFAH1B2	platelet-activating factor acetylhydrolase, isoform Ib, beta subunit 30kDa	5049	11	11q23	MLCLS	5049, CCDS8380.1, ENSG00000168092, P68402, PAFAH1B2, Q6IBR6
PAX3	paired box gene 3	5077	2	2q35	alveolar rhabdomyosarcoma	5077, CCDS2448.1, CDHS, ENSG00000135903, HUP2, MGC120381, MGC120382, MGC120383, MGC120384, MGC134778, P23760, PAX3, Q12777, Q494Z3, Q494Z4, WS1
PAX5	paired box gene 5 (B-cell lineage specific activator protein)	5079	9	9p13	NHL, ALL, B-ALL	5079, BSAP, CCDS6607.1, ENSG00000196092, PAX5, Q02548, Q5VVI9
PAX7	paired box gene 7	5081	1	1p36.2-p36.12	alveolar rhabdomyosarcoma	5081, CCDS186.1, ENSG00000009709, HUP1, P23759, PAX7, PAX7B, Q0VA99, Q2PJS5
PAX8	paired box gene 8	7849	2	2q12-q14	follicular thyroid	7849, ENSG00000125618, PAX8
PBRM1	polybromo 1	55193	3	3p21	clear cell renal carcinoma, breast	55193, BAF180, C9J053, C9J409, C9J9L6, C9JCJ2, C9JPI5, C9JQF1, CCDS2860, MGC156155, MGC156156, PB1, PBRM1, Q6IRX1, Q9NUX9
PBX1	pre-B-cell leukemia transcription factor 1	5087	1	1q23	pre B-ALL, myoepithelioma	5087, CCDS1246.1, P40424, PBX1, Q5T487, Q68DD6
PCM1	pericentriolar material 1 (PTC4)	5108	8	8p22-p21.3	papillary thyroid, CML, MPD	5108, B4DWY1, B4DYD5, ENSG00000078674, PCM1, PTC4, Q15154
PCSK7	proprotein convertase subtilisin/kexin type 7	9159	11	11q23.3	MLCLS	9159, CCDS8382.1, ENSG00000160613, LPC, PC7, PC8, PCSK7, Q16549, Q3C1X1, Q53GM4, Q6PK65, Q96FK8, SPC7
PDE4DIP	phosphodiesterase 4D interacting protein (myomegalin)	9659	1	1q12	MPD	9659, CCDS30824.1, ENSG00000178104, PDE4DIP, Q5VU42, Q5VU43, Q5VU47, Q68DU2, Q86T40, Q8N3W0, Q9HCP3, Q9HCP4, Q9HCP5
PDGFB	platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog)	5155	22	22q12.3-q13.1	DFSP	5155, A2NWD3, CCDS13987.1, ENSG00000100311, FLJ12858, P01127, P78450, PDGF2, PDGFB, Q6FHE7, Q9UE56, Q9UE57, SIS, SSV, c-sis
PDGFRA	platelet-derived growth factor, alpha-receptor	5156	4	4q11-q13	GIST, idiopathic hypereosinophilic syndrome, paediatric GBM	5156, CCDS3495.1, CD140A, CD140a, ENSG00000134853, MGC74795, P16234, PDGFR2, PDGFRA, Rhe-PDGFRA
PDGFRB	platelet-derived growth factor receptor, beta polypeptide	5159	5	5q31-q32	MPD, AML, CMML, CML	5159, CCDS4303.1, CD140B, CD140b, ENSG00000113721, JTK12, P09619, PDGF-R-beta, PDGFR, PDGFR1, PDGFRB
PER1	period homolog 1 (Drosophila)	5187	17	17p13.1-17p12	AML, CMML	5187, A2I2P6, CCDS11131.1, ENSG00000179094, O15534, PER, PER1, Q6IN51, Q8N6U1, Q9H2D0, RIGUI
PHF6	PHD finger protein 6	84295	X	Xq26.3	ETP ALL	84295, BORJ, ENSG00000156531, MGC14797, PHF6
PHOX2B	paired-like homeobox 2b	8929	4	4p12	neuroblastoma	8929, PHOX2B
PICALM	phosphatidylinositol binding clathrin assembly protein (CALM)	8301	11	11q14	TALL, AML,	8301, CALM, CCDS8272.1, CLTH, ENSG00000073921, PICALM, Q13492, Q4LE54
PIK3CA	phosphoinositide-3-kinase, catalytic, alpha polypeptide	5290	3	3q26.3	colorectal, gastric, gliobastoma, breast	5290, ENSG00000121879, MGC142161, MGC142163, P42336, PI3K, PIK3CA, p110-alpha
PIK3R1	phosphoinositide-3-kinase, regulatory subunit 1 (alpha)	5295	5	5q13.1	gliobastoma, ovarian, colorectal	5295, CCDS3993.1, CCDS3995.1, ENSG00000145675, GRB1, P27986, PIK3R1, p85-ALPHA
PIM1	pim-1 oncogene	5292	6	6p21.2	NHL	5292, ENSG00000137193, P11309, PIM, PIM1
PLAG1	pleiomorphic adenoma gene 1	5324	8	8q12	salivary adenoma	5324, CCDS6165.1, ENSG00000181690, PLAG1, Q59GH8, Q6DJT9, Q9Y4L2
PML	promyelocytic leukemia	5371	15	15q22	APL, ALL	5371, CCDS10255.1, ENSG00000140464, MYL, PML, PP8675, RNF71, TRIM19
PMX1	paired mesoderm homeo box 1	5396	1	1q24	AML	5396, CCDS1291.1, ENSG00000116132, PMX1, PRRX1
PNUTL1	peanut-like 1 (Drosophila)	5413	22	22q11.2	AML	5413, CCDS13764.1, ENSG00000184702, H5, HCDCREL-1, O95648, PNUTL1, Q99719, SEPT5
POU2AF1	POU domain, class 2, associating factor 1 (OBF1)	5450	11	11q23.1	NHL	5450, BOB1, CCDS31675.1, ENSG00000110777, OBF-1, OBF1, OCAB, POU2AF1, Q16633
POU5F1	POU domain, class 5, transcription factor 1	5460	6	6p21.31	sarcoma	5460, ENSG00000230336, MGC22487, OCT3, OCT4, OTF3, OTF3C, OTF3P1, OTF4, Oct4, POU5F1, POU5F1P1
PPARG	peroxisome proliferative activated receptor, gamma	5468	3	3p25	follicular thyroid	5468, CCDS2609.1, ENSG00000132170, HUMPPARG, NR1C3, PPARG, PPARG1, PPARG2
PPP2R1A	protein phosphatase 2, regulatory subunit A, alpha	5518	19	19q13.41	clear cell ovarian carcinoma	5518, CCDS12849.1, ENSG00000105568, MGC786, P30153, PPP2R1A, PR65A, Q6ICQ3, Q96DH3
PRCC	papillary renal cell carcinoma (translocation-associated)	5546	1	1q21.1	papillary renal	5546, CCDS1157, CCDS1158.1, ENSG00000143294, MGC17178, MGC4723, PRCC, PRCC_ENST00000353233, Q5SZ06, Q92733, Q96FT4, RCCP1, TPRC
PRDM1	PR domain containing 1, with ZNF domain	639	6	6q21	DLBCL	639, BLIMP1, CCDS5054, ENSG00000057657, MGC118922, MGC118923, MGC118924, MGC118925, O75626, PRDI-BF1, PRDM1, Q5T4E8, Q658W0, RP1-134E15_1
PRDM16	PR domain containing 16	63976	1	1p36.23-p33	MDS, AML	63976, ENSG00000142611, KIAA1675, MEL1, PFM13, PRDM16, Q5VU54, Q9HAZ2
PRKAR1A	protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)	5573	17	17q23-q24	papillary thyroid	5573, CAR, CCDS11678.1, CNC, CNC1, DKFZp779L0468, ENSG00000108946, MGC17251, P10644, PKR1, PPNAD1, PRKAR1, PRKAR1A, Q68DQ4, Q96P62, TSE1
PRO1073	PRO1073 protein (ALPHA)	29005	11	11q31.1	renal cell carcinoma (childhood epithelioid)	29005, PRO1073, Q9UHZ2
PSIP2	PC4 and SFRS1 interacting protein 2 (LEDGF)	11168	9	9p22.2	AML	11168, CCDS6480.1, ENSG00000164985, PSIP1, PSIP2, Q05CM9, Q8N4N4
PTCH	Homolog of Drosophila Patched gene	5727	9	9q22.3	skin basal cell , medulloblastoma	5727, BCNS, CCDS6714.1, ENSG00000185920, FLJ26746, FLJ42602, HPE7, NBCCS, PTC, PTC1, PTCH, PTCH1, Q13635, Q59FG5, Q5R1U7, Q5R1V0, Q5VZC2, Q6TKP8, Q6TKP9, Q6TKQ0, Q86XG7, RP11-435O5_3
PTEN	phosphatase and tensin homolog gene	5728	10	10q23.3	glioma, prostate, endometrial	5728, BZS, ENSG00000171862, MGC11227, MHAM, MMAC1, P60484, PTEN, PTEN1, TEP1
PTPN11	protein tyrosine phosphatase, non-receptor type 11	5781	12	12q24.1	JMML, AML, MDS	5781, BPTP3, CCDS9163.1, CFC, ENSG00000179295, MGC14433, NS1, PTP-1D, PTP2C, PTPN11, Q06124, Q16344, SH-PTP2, SH-PTP3, SHP-2, SHP2
RAB5EP	rabaptin, RAB GTPase binding effector protein 1 (RABPT5)	9135	17	17p13	CMML	9135, ENSG00000029725, Q05BX6, Q15276, RAB5EP, RABEP1, RABPT5, neurocrescin, rabaptin-5
RAD51L1	RAD51-like 1 (S. cerevisiae) (RAD51B)	5890	14	14q23-q24.2	lipoma, uterine leiomyoma	5890, CCDS9789.1, ENSG00000182185, MGC34245, O15315, R51H2, RAD51B, RAD51L1, REC2, hREC2
RAF1	v-raf-1 murine leukemia viral oncogene homolog 1	5894	3	3p25	pilocytic astrocytoma	5894, CCDS2612.1, CRAF, ENSG00000132155, P04049, RAF1, Raf-1, c-Raf
RALGDS	ral guanine nucleotide dissociation stimulator	5900	9	9q34.3	PMBL, Hodgkin Lymphona,	5900, CCDS6959.1, ENSG00000160271, FLJ20922, Q12967, Q5T7V4, Q6ZSD5, Q8N4Y1, Q8NF31, Q8WU11, Q9HAX8, Q9HAX9, Q9HAY0, RALGDS, RGF, RalGEF
RANBP17	RAN binding protein 17	64901	5	5q34	ALL	64901, CCDS34287.1, ENSG00000204764, FLJ32916, Q546R4, Q8IU74, Q8IVM9, Q96M10, Q9H2T7, RANBP17
RAP1GDS1	RAP1, GTP-GDP dissociation stimulator 1	5910	4	4q21-q25	T-ALL	5910, ENSG00000138698, GDS1, MGC118859, MGC118861, P52306, Q4QQI8, Q9BUX6, RAP1GDS1
RARA	retinoic acid receptor, alpha	5914	17	17q12	APL	5914, CCDS11366.1, ENSG00000131759, NR1B1, RAR, RARA
RB1	retinoblastoma gene	5925	13	13q14	retinoblastoma, sarcoma, breast, small cell lung	5925, ENSG00000139687, OSRC, P06400, RB, RB1
RBM15	RNA binding motif protein 15	64783	1	1p13	acute megakaryocytic leukemia	64783, A1A693, CCDS822.1, ENSG00000162775, OTT, OTT1, Q59EY1, Q96T37, RBM15
REL	v-rel reticuloendotheliosis viral oncogene homolog (avian)	5966	2	2p13-p12	Hodgkin Lymphoma	5966, C-Rel, CCDS1864.1, ENSG00000162924, I-Rel, REL
RET	ret proto-oncogene	5979	10	10q11.2	medullary thyroid, papillary thyroid, pheochromocytoma, NSCLC	5979, CCDS7200.1, CDHF12, ENSG00000165731, HSCR1, MEN2A, MEN2B, MTC1, P07949, PTC, RET, RET-ELE1, RET51
ROS1	v-ros UR2 sarcoma virus oncogene homolog 1 (avian)	6098	6	6q22	glioblastoma, NSCLC	6098, ENSG00000047936, MCF3, P08922, ROS, ROS1, RP1-179P9_1
RPL22	ribosomal protein L22 (EAP)	6146	1	1p36.31	AML, CML	6146, CCDS58.1, EAP, RPL22
RPN1	ribophorin I	6184	3	3q21.3-q25.2	AML	6184, CCDS3051.1, ENSG00000163902, OST1, P04843, Q53EP4, Q68DT1, Q6IBR0, Q96HX3, RPN1
RUNDC2A	RUN domain containing 2A	84127	16	16p13.13	PMBL, Hodgkin Lymphona,	84127, CCDS10553.1, ENSG00000140660, FLJ12363, Q9HA26, RUNDC2A
RUNX1	runt-related transcription factor 1 (AML1)	861	21	21q22.3	AML, preB- ALL, T-ALL	861, AML1, AMLCR1, CBFA2, CCDS13639.1, ENSG00000159216, PEBP2A2, Q01196, RUNX1
RUNXBP2	runt-related transcription factor binding protein 2 (MOZ/ZNF220)	7994	8	8p11	AML	7994, CCDS6124.1, ENSG00000083168, MOZ, MYST3, Q92794, RUNXBP2, ZNF220
SDC4	syndecan 4	6385	20	20q12	NSCLC	6385, CCDS13350.1, ENSG00000124145, MGC22217, P31431, Q53FN9, Q6FGN3, SDC4, SYND4
SEPT6	septin 6	23157	X	Xq24	AML	23157, CCDS14584.1, ENSG00000125354, KIAA0128, MGC16619, MGC20339, Q14141, Q5JTK3, Q6B514, Q6NT82, Q8NFH9, RP5-876A24_2, SEP2, SEPT2, SEPT6
SET	SET translocation	6418	9	9q34	AML	2PP2A, 6418, CCDS6907.1, ENSG00000119335, ENSG00000181555, I2PP2A, IGAAD, PHAPII, SET, SETD2, SETD2_ENST00000409792, TAF-IBETA
SETD2	SET domain containing 2	29072	3	3p21.31	clear cell renal carcinoma	29072, ENSG00000181555, SETD2
SF3B1	splicing factor 3b, subunit 1, 155kDa	23451	2	2q33.1	myelodysplastic syndrome	23451, A0JLT9, A0PJH5, CCDS33356.1, ENSG00000115524, O75533, PRP10, PRPF10, Q32Q20, Q7Z497, Q9NTB4, SAP155, SF3B1, SF3b155
SFPQ	splicing factor proline/glutamine rich(polypyrimidine tract binding protein associated)	6421	1	1p34.3	papillary renal cell	6421, CCDS388.1, ENSG00000116560, P23246, PSF, Q5SZ71, Q6PIX2, Q86VG2, Q9BSV4, SFPQ
SFRS3	splicing factor, arginine/serine-rich 3	6428	6	6p21	follicular lymphoma	6428, CCDS4823.1, ENSG00000112081, P84103, Q5R3K0, SFRS3, SRSF3, SRp20
SH3GL1	SH3-domain GRB2-like 1 (EEN)	6455	19	19p13.3	AL	6455, CCDS32874.1, CNSA1, EEN, ENSG00000141985, Q6FGM0, Q99961, Q9BVL7, Q9BWP4, Q9UQD4, SH3D2B, SH3GL1, SH3P8
SIL	TAL1 (SCL) interrupting locus	6491	1	1p32	T-ALL	6491, CCDS548.1, ENSG00000123473, Q15468, Q5T0C6, Q5T0C9, Q5T0D0, SIL, STIL
SLC34A2	solute carrier family 34 (sodium phosphate), member 2	10568	4	4p15.2	NSCLC	10568, CCDS3435.1, ENSG00000157765, FLJ90534, NAPI-3B, NAPI-IIb, NPTIIb, O95436, SLC34A2
SLC45A3	solute carrier family 45, member 3	85414	1	1q32	prostate	85414, CCDS1458.1, ENSG00000158715, IPCA-6, IPCA6, PCANAP6, PRST, Q658X7, Q96JT2, SLC45A3
SMARCA4	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4	6597	19	19p13.2	NSCLC	6597, BAF190, BRG1, CCDS12253.1, ENSG00000127616, FLJ39786, P51532, Q59FZ6, SMARCA4, SNF2, SNF2-BETA, SNF2L4, SNF2LB, SWI2, hSNF2b
SMARCB1	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1	6598	22	22q11	malignant rhabdoid	6598, BAF47, CCDS13817.1, ENSG00000099956, INI1, Ini1, Q12824, RDT, SMARCB1, SNF5, SNF5L1, Sfh1p, Snr1, hSNFS
SMO	smoothened homolog (Drosophila)	6608	7	7q31-q32	skin basal cell	6608, CCDS5811.1, ENSG00000128602, Gx, NP_005622, Q99835, Q9Y2Y5, SMO, SMOH
SOCS1	suppressor of cytokine signaling 1?	8651	16	16p13.13	Hodgkin Lymphoma, PMBL	8651, CCDS10546.1, CIS1, CISH1, Cish1, ENSG00000185338, JAB, O15524, Q4JHT5, SOCS-1, SOCS1, SSI-1, SSI1, TIP3
SOX2	SRY (sex determining region Y)-box 2	6657	3	3q26.3-q27	NSCLC, oesophageal squamous carcinoma	6657, ANOP3, CCDS3239.1, ENSG00000181449, MCOPS3, MGC2413, P48431, Q9UD89, SOX2
SRGAP3	SLIT-ROBO Rho GTPase activating protein 3	9901	3	3p25.3	pilocytic astrocytoma	9901, ARHGAP14, CCDS2572.1, ENSG00000196220, KIAA0411, MEGAP, SRGAP2, SRGAP3, WRP
SRSF2	serine/arginine-rich splicing factor 2	6427	17	17q25	MDS, CLL	6427, CCDS11749.1, Q01130, Q53FN0, SFRS2, SRSF2
SS18	synovial sarcoma translocation, chromosome 18	6760	18	18q11.2	synovial sarcoma	6760, CCDS32807.1, ENSG00000141380, Q15532, Q4VAX2, Q8TDQ9, SS18, SSXT, SYT
SS18L1	synovial sarcoma translocation gene on chromosome 18-like 1	26039	20	20q13.3	synovial sarcoma	26039, CCDS13491.1, ENSG00000184402, KIAA0693, O75177, Q6MZV9, Q6XYD9, SS18L1
SSH3BP1	spectrin SH3 domain binding protein 1	10006	10	10p11.2	AML	10006, ABI-1, ABI1, CCDS7150.1, E3B1, SSH3BP1
SSX1	synovial sarcoma, X breakpoint 1	6756	X	Xp11.23-p11.22	synovial sarcoma	6756, CCDS14290.1, ENSG00000126752, MGC150425, MGC5162, Q16384, RP11-552E4_1, SSRC, SSX1
SSX2	synovial sarcoma, X breakpoint 2	6757	X	Xp11.23-p11.22	synovial sarcoma	6757, CCDS14345.1, ENSG00000157950, HD21, HOM-MEL-40, MGC119055, MGC15364, MGC3884, Q8WWZ9, Q9NZK4, RP11-552J9_2, SSX, SSX2
SSX4	synovial sarcoma, X breakpoint 4	6759	X	Xp11.23	synovial sarcoma	6759, CCDS35240.1, ENSG00000204645, MGC119056, MGC12411, O60224, SSX4
STK11	serine/threonine kinase 11 gene (LKB1)	6794	19	19p13.3	NSCLC, pancreatic	6794, ENSG00000118046, LKB1, PJS, Q15831, STK11
STL	Six-twelve leukemia gene	7955	6	6q23	B-ALL
SUFU	suppressor of fused homolog (Drosophila)	51684	10	10q24.32	medulloblastoma	51684, CCDS7537.1, ENSG00000121410, PRO1280, Q5JSM1, Q5JWB5, Q9UMX1, RP11-47A8_1, SUFU, SUFUH, SUFUXL
SUZ12	suppressor of zeste 12 homolog (Drosophila)	23512	17	17q11.2	endometrial stromal tumours	23512, CCDS11270.1, CHET9, ENSG00000178691, JJAZ1, KIAA0160, Q15022, SUZ12
SYK	spleen tyrosine kinase	6850	9	9q22	MDS, peripheral T-cell lymphoma	6850, CCDS6688.1, ENSG00000165025, P43405, SYK
TAF15	TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa	8148	17	17q11.1-q11.2	extraskeletal myxoid chondrosarcomas, ALL	8148, CCDS32623.1, ENSG00000172660, Npl3, Q86X94, Q92804, RBP56, TAF15, TAF2N, hTAFII68
TAL1	T-cell acute lymphocytic leukemia 1 (SCL)	6886	1	1p32	lymphoblastic leukemia/biphasic	6886, CCDS547.1, ENSG00000162367, P17542, Q16509, Q9UE36, SCL, TAL1, TCL5, tal-1
TAL2	T-cell acute lymphocytic leukemia 2	6887	9	9q31	T-ALL	6887, CCDS6767.1, Q16559, TAL2
TCEA1	transcription elongation factor A (SII), 1	6917	8	8q11.2	salivary adenoma	6917, ENSG00000187735, TCEA1
TCF1	transcription factor 1, hepatic (HNF1)	6927	12	12q24.2	hepatic adenoma, hepatocellular ca	6927, CCDS9209.1, ENSG00000135100, HNF1, HNF1A, LFB1, MODY3, P20823, TCF1
TCF12	transcription factor 12 (HTF4, helix-loop-helix transcription factors 4)	6938	15	15q21	extraskeletal myxoid chondrosarcoma	6938, CCDS10160.1, ENSG00000140262, HEB, HTF4, HsT17266, Q86VM2, Q9NQY1, Q9NQY2, Q9NQY3, Q9NQY4, Q9NQY5, Q9NQY6, Q9NQY7, Q9NQY9, TCF12
TCF3	transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)	6929	19	19p13.3	pre B-ALL	6929, CCDS12074.1, E2A, ENSG00000071564, ITF1, MGC129647, MGC129648, P15923, Q6PJU3, TCF3
TCF7L2	transcription factor 7-like 2	6934	10	10q25.3	colorectal	6934, CCDS7576.1, ENSG00000148737, Q6FHW4, TCF-4, TCF4, TCF7L2
TCL1A	T-cell leukemia/lymphoma 1A	8115	14	14q32.1	T-CLL	8115, CCDS9941.1, ENSG00000100721, P56279, TCL1, TCL1A
TCL6	T-cell leukemia/lymphoma 6	27004	14	14q32.1	T-ALL	27004, CCDS9940.1, ENSG00000187621, P56847, Q9NPH1, TCL6
TET2	tet oncogene family member 2	54790	4	4q24	MDS	54790, A7E237, B5MDU0, C3W8F4, ENSG00000168769, FLJ20032, KIAA1546, MGC125715, Q6N021, TET2, TET2-202
TFE3	transcription factor binding to IGHM enhancer 3	7030	X	Xp11.22	papillary renal, alveolar soft part sarcoma, renal	7030, CCDS14315.2, ENSG00000068323, RCCP2, TFE3, TFEA
TFEB	transcription factor EB	7942	6	6p21	renal (childhood epithelioid)	7942, AlphaTFEB, CCDS4858.1, ENSG00000112561, P19484, Q4VXW8, Q4VXX0, Q5QPI1, Q5QPI2, Q709A5, Q709A8, Q709A9, Q86WB1, TCFEB, TFEB
TFG	TRK-fused gene	10342	3	3q11-q12	papillary thyroid, ALCL, NSCLC	10342, CCDS2939.1, ENSG00000114354, Q7Z426, Q7Z427, Q92734, Q969I2, TF6, TFG
TFPT	TCF3 (E2A) fusion partner (in childhood Leukemia)	29844	19	19q13	pre-B ALL	29844, CCDS12878.1, ENSG00000105619, P0C1Z6, TFPT
TFRC	transferrin receptor (p90, CD71)	7037	3	3q29	NHL	7037, CCDS3312.1, CD71, ENSG00000072274, P02786, Q1HE24, TFR1, TFRC
THRAP3	thyroid hormone receptor associated protein 3 (TRAP150)	9967	1	1p34.3	aneurysmal bone cysts	9967, CCDS405.1, ENSG00000054118, FLJ22082, MGC133082, MGC133083, Q05D20, Q6P0P7, Q6PJV4, Q7Z5U1, Q9Y2W1, THRAP3, TRAP150
TIF1	transcriptional intermediary factor 1 (PTC6,TIF1A)	8805	7	7q32-q34	APL	8805, CCDS5847.1, ENSG00000122779, P04720, PTC6, RNF82, TF1A, TIF1, TIF1A, TIF1ALPHA, TRIM24, Tif1a, hTIF1
TLX1	T-cell leukemia, homeobox 1 (HOX11)	3195	10	10q24	T-ALL	3195, A1L4G3, CCDS7510.1, ENSG00000107807, HOX11, P31314, Q5VXP2, Q9UD59, TCL3, TLX1
TLX3	T-cell leukemia, homeobox 3 (HOX11L2)	30012	5	5q35.1	T-ALL	30012, CCDS34288.1, ENSG00000164438, HOX11L2, O43711, RNX, TLX3
TMPRSS2	transmembrane protease, serine 2	7113	21	21q22.3	prostate	7113, CCDS33564.1, ENSG00000184012, O15393, PRSS10, Q96T73, TMPRSS2
TNFAIP3	tumor necrosis factor, alpha-induced protein 3	7128	6	6q23	marginal zone B-cell lymphomas, Hodgkin's lymphoma, primary mediastinal B cell lymphoma	7128, A20, CCDS5187.1, ENSG00000118503, MGC104522, MGC138687, MGC138688, OTUD7C, P21580, Q5PY18, Q5VXQ8, Q5VXQ9, Q5VXR0, TNFA1P2, TNFAIP3
TNFRSF14	tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)	8764	1	1p36.32	follicular lymphoma	8764, ATAR, CCDS43.1, ENSG00000157873, HVEA, HVEM, LIGHTR, Q6IB95, Q8N634, Q92956, TNFRSF14, TR2
TNFRSF17	tumor necrosis factor receptor superfamily, member 17	608	16	16p13.1	intestinal T-cell lymphoma	608, BCM, BCMA, CCDS10552.1, CD269, ENSG00000048462, Q02223, Q6PE46, TNFRSF17
TNFRSF6	tumor necrosis factor receptor superfamily, member 6 (FAS)	355	10	10q24.1	TGCT, nasal NK/T lymphoma, skin squamous cell ca -burn scar-related	355, ALPS1A, APO-1, APT1, CCDS7393.1, CD95, ENSG00000026103, FAS, FAS1, FASTM, P25445, Q5T9P1, Q6ICT6, Q8IUB6, Q8IUB7, TNFRSF6
TOP1	topoisomerase (DNA) I	7150	20	20q12-q13.1	AML*	7150, CCDS13312.1, ENSG00000198900, P11387, Q6NWZ5, Q6PK95, Q9BVT2, RP3-511B24_2, TOP1, TOPI
TP53	tumor protein p53	7157	17	17p13	breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types	7157, CCDS11118.1, ENSG00000141510, LFS1, P04637, P53, TP53, TRP53, p53
TPM3	tropomyosin 3	7170	1	1q22-q23	papillary thyroid, ALCL, NSCLC	7170, CCDS1060.1, ENSG00000143549, TPM3
TPM4	tropomyosin 4	7171	19	19p13.1	ALCL	7171, CCDS12338.1, ENSG00000167460, P67936, Q5U0D9, TPM4
TPR	translocated promoter region	7175	1	1q25	papillary thyroid	7175, A0PJC9, P12270, TPR
TRA@	T cell receptor alpha locus	6955	14	14q11.2	T-ALL
TRB@	T cell receptor beta locus	6957	7	7q35	T-ALL
TRD@	T cell receptor delta locus	6964	14	14q11	T-cell leukemia
TRIM27	tripartite motif-containing 27	5987	6	6p22	papillary thyroid	5987, CCDS4654.1, DASS-46L4_6, ENSG00000234495, RFP, RNF76, TRIM27
TRIM33	tripartite motif-containing 33 (PTC7,TIF1G)	51592	1	1p13	papillary thyroid	51592, ENSG00000197323, FLJ32925, PTC7, Q9UPN9, RFG7, TF1G, TIF1G, TIF1GAMMA, TIFGAMMA, TRIM33
TRIP11	thyroid hormone receptor interactor 11	9321	14	14q31-q32	AML	9321, CCDS9899.1, CEV14, ENSG00000100815, Q15643, Q6MZL5, TRIP11, Trip230
TSHR	thyroid stimulating hormone receptor	7253	14	14q31	toxic thyroid adenoma	7253, CCDS9872.1, ENSG00000165409, LGR3, MGC75129, TSHR, hTSHR-I
TTL	tubulin tyrosine ligase	150465	2	2q13	ALL	150465, 2410003M22Rik, 284076, CCDS2096.1, ENSG00000114999, ENSG00000170703, FLJ35808, MGC46235, Q585T3, Q8N841, Q8NG68, TTL, TTLL6_ENST00000393382, TTL_6
U2AF1	U2 small nuclear RNA auxiliary factor 1	7307	21	21q22.3	CLL, MDS	7307, CCDS13694.1, DKFZp313J1712, ENSG00000160201, FP793, Q01081, Q71RF1, Q7Z780, RN, RNU2AF1, U2AF1, U2AF35, U2AFBP
USP6	ubiquitin specific peptidase 6 (Tre-2 oncogene)	9098	17	17p13	aneurysmal bone cysts	9098, ENSG00000129204, HRP1, TRE17, TRE2, Tre-2, USP6
VHL	von Hippel-Lindau syndrome gene	7428	3	3p25	renal, hemangioma, pheochromocytoma	7428, A0PJF6, CCDS2597.1, ENSG00000134086, HRCA1, P40337, RCA1, VHL, VHL1
VTI1A	vesicle transport through interaction with t-SNAREs homolog 1A	143187	10	10q25.2	colorectal	143187, CCDS7575.2, ENSG00000151532, MVti1, Q5W0D7, VTI1A, Vti1-rp2
WHSC1	Wolf-Hirschhorn syndrome candidate 1(MMSET)	7468	4	4p16.3	MM	7468, B3VCH6, CCDS33940, D3DVQ2, FLJ23286, KIAA1090, MGC176638, MMSET, NSD2, O96028, REIIBP, TRX5, WHS, WHSC1, WHSC1_ENST00000382891
WHSC1L1	Wolf-Hirschhorn syndrome candidate 1-like 1 (NSD3)	54904	8	8p12	AML	54904, CCDS6105.1, ENSG00000147548, WHSC1L1
WIF1	WNT inhibitory factor 1	11197	12	12q14.3	pleomorphic salivary gland adenoma	11197, CCDS8971.1, ENSG00000156076, WIF-1, WIF1
WT1	Wilms tumour 1 gene	7490	11	11p13	Wilms, desmoplastic small round cell tumor	7490, ENSG00000184937, GUD, WAGR, WIT-2, WT1, WT33
WTX	family with sequence similarity 123B (FAM123B)	139285	X	Xq11.1	Wilms tumour	139285, CCDS14377.1, ENSG00000184675, FAM123B, FLJ39827, RP11-403E24_2, WTX
WWTR1	WW domain containing transcription regulator 1	607392	3	3q23-q24	epitheliod hemangioendothelioma	25937, CCDS3144.1, DKFZP586I1419, ENSG00000018408, Q9GZV5, TAZ, WWTR1
XPO1	exportin 1 (CRM1 homolog, yeast)	7514	2	2p15	CLL	7514, CCDS33205.1, CRM1, DKFZp686B1823, ENSG00000082898, O14980, XPO1
YWHAE	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide (14-3-3 epsilon)	7531	17	17p13.3	edometrial stromal sarcoma	14-3-3 epsilon, 14-3-3E, 7531, CCDS11001.1, ENSG00000108953, FLJ45465, KCIP-1, MDCR, MDS, P62258, Q4VJB6, Q53XZ5, YWHAE
ZNF145	zinc finger protein 145 (PLZF)	7704	11	11q23.1	APL	7704, CCDS8367.1, ENSG00000109906, PLZF, Q05516, Q59H43, Q71UL5, Q71UL6, Q71UL7, ZBTB16, ZNF145
ZNF198	zinc finger protein 198	7750	13	13q11-q12	MPD, NHL	7750, ENSG00000121741, FIM, MYM, Q5W0Q3, Q9UBW7, RAMP, ZMYM2, ZNF198
ZNF278	zinc finger protein 278 (ZSG)	23598	22	22q12-q14	Ewing sarcoma	23598, CCDS13896.1, ENSG00000100105, PATZ1, Q9HD72, ZNF278
ZNF331	zinc finger protein 331	55422	19	19q13.3-q13.4	follicular thyroid adenoma	55422, CCDS33102.1, ENSG00000130844, Q68D63, Q6PK05, Q71QC3, Q71QC4, Q71QC5, Q71QC6, Q71QC8, Q71QC9, Q8NBU2, Q9NQX6, RITA, ZNF331, ZNF361, ZNF463
ZNF384	zinc finger protein 384 (CIZ/NMP4)	171017	12	12p13	ALL	171017, CCDS8557.1, ENSG00000126746, ZNF384
ZNF521	zinc finger protein 521	25925	18	18q11.2	ALL	25925, CCDS32806.1, DKFZp564D0764, EHZF, ENSG00000198795, Evi3, MGC142182, MGC142208, Q8IXI0, Q8IYZ2, Q8TES6, Q96K83, Q9C065, Q9HAL5, Q9UFK4, ZNF521
ZNF9	zinc finger protein 9 (a cellular retroviral nucleic acid binding protein)	7555	3	3q21	aneurysmal bone cysts	7555, CCDS3056.1, CNBP, DM2, ENSG00000169714, P62633, Q4JGY0, Q4JGY1, Q5U0E9, Q6T598, RNF163, ZNF9
ZRSR2	zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2	8233	X	Xp22.1	MDS, CLL	8233, ENSG00000169249, MGC142014, MGC142040, U2AF1-RS2, U2AF1L2, U2AF1RS2, URP, ZRSR2

A, amplification; AEL, acute eosinophilic leukemia; AL, acute leukemia; ALCL, anaplastic large-cell lymphoma; ALL, acute lymphocytic leukemia; AML, acute myelogenous leukemia; AML*, acute myelogenous leukemia (primarily treatment associated); APL, acute promyelocytic leukemia; B-ALL, B-cell acute lymphocytic leukaemia; B-CLL, B-cell Lymphocytic leukemia; B-NHL, B-cell Non-Hodgkin Lymphoma; CLL, chronic lymphatic leukemia; CML, chronic myeloid leukemia; CMML, chronic myelomonocytic leukemia; CNS, central nervous system; D, large deletion; DFSP, dermatofibrosarcoma protuberans; DLBL, diffuse large B-cell lymphoma; DLCL, diffuse large-cell lymphoma; Dom, dominant; E, epithelial; F, frameshift; GIST, gastrointestinal stromal tumour; JMML, juvenile myelomonocytic leukemia; L, leukaemia/lymphoma; M, mesenchymal; MALT, mucosa-associated lymphoid tissue lymphoma; MDS, myelodysplastic syndrome; Mis, Missense; MLCLS, mediastinal large cell lymphoma with sclerosis; MM, multiple myeloma; MPD, Myeloproliferative disorder; N, nonsense; NHL, non-Hodgkin lymphoma; NK/T, natural killer T cell; NSCLC, non small cell lung cancer; O, other; PMBL, primary mediastinal B-cell lymphoma; pre-B All, pre-B-cell acute lymphoblastic leukaemia; Rec, recesive; S, splice site; T, translocation; T-ALL, T-cell acute lymphoblastic leukemia; T-CLL, T-cell chronic lymphocytic leukaemia; TGCT, testicular germ cell tumour; T-PLL, T cell prolymphocytic leukaemia;